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ABSTRACT

The goal of this dissertation research is to understand proteolytic
processing of the polymerase polyprotein in murine coronavirus mouse
hepatitis virus (MHV).

MHV polymerase is encoded by gene 1 as a

polyprotein, which is proteolytically processed into mature proteins by three
proposed proteinase domains. The first papain-like cysteine proteinase
domain (PCP-1) has been shown to autocleave the N-terminal peptide, p28
from the putative MHV polymerase polyprotein. This study was designed to
further understand the p28 processing event, focusing on the catalytic sites of
PCP-1 and the cleavage site recognized by PCP-1 to release p28.

The predicted PCP-1 domain at the 5'-end 3.5-4.3 kb of gene 1 was
confirmed by in-frame deletion analysis. In addition, the proteolytic activity
of PCP-1 was shown to be partially inhibited by cysteine proteinase inhibitors
but not by serine, aspartic, or metallo- proteinases inhibitors, supporting the
proposal that this proteinase is a papain-like cysteine proteinase. By sitespecific mutagenesis, Cys-1137 and His-1288 were identified to be the
catalytic sites of PCP-1. Thus, MHV PCP-1 is indeed a new member of the
family ofpapain-like cysteine proteinases.

To determine the p28 cleavage site recognized by MHV PCP-1, the
radiolabeled in vitro cleaved product adjacent to p28 was subjected to Niv

terminal sequencing, and the result indicated that the cleavage occurred
between Gly-24 7 and Val-248. By extensive site-specific mutagenesis of
amino acid residues surrounding this cleavage site, Gly-247(Pl) and Arg-246
(P2) were characterized as major determinants for cleavage site recognition

by MHV PCP-1. In addition, some surrounding residues such as Arg-243 (P5)
are probably required to maintain an important conformation of the cleavage
site.

This work is an important step towards the understanding of the
complete proteolytic processing pathway of MHV polymerase polyprotein.
Future studies can be directed toward characterizing additional putative
cleavage sites for MHV PCP-1 and determining what effect blocking the
cleavage of p28 will have on coronavirus RNA replication.
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CHAPTER I
IN'IRODUCTION

eoronaviruses and their replication
Coronaviruses are a family of large, enveloped positive-strand (+)
RNA viruses which are widespread in nature (Wege et al., 1982; Siddell et

al., 1983). This family of viruses consists of 11 members, including avian
infectious bronchitis virus (IBV), mouse hepatitis virus (MHV), bovine
coronavirus (BCV), and human coronavirus (HCV). Coronaviruses are of
clinical and economical importance because they cause a variety of
diseases, mainly in respiratory, gastrointestinal and neurological systems,
such as common cold in humans; enteritis in cows, pigs, turkeys, cats and
mice; and encephalitis in mice and cats. Mouse hepatitis virus (MHV), a
prototype coronavirus, has been extensively studied to understand the
molecular biology of coronaviruses (Spaan et al., 1988; Lai, 1990). The
neurotropic strain of mouse hepatitis virus (MHV-JHM) can induce
demyelination after injection into the brains of mice and serves as a model
system for studying demyelination diseases such as multiple sclerosis
(Weiner, 1973; Knobler et al., 1982; Fleming et al., 1987).

The coronavirion is a crown-like particle with a lipid-bilayer
membrane outside and a helical encapsidated RNA genome inside (Siddell

et al., 1983).

These enveloped viruses are composed of three or four
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atructural proteins: the petal-shaped spike protein (S) projecting from the
surface of the envelope giving coronavirus its distinctive morphology, the
membrane embedded matrix protein (M), the hemagglutinin esterase (HE,
expressed only in some virus strains) and the nucleocapsid protein (N)
which surrounds the virion RNA.

The viral genomic RNA is a single-

strand positive-sense RNA molecule which is capped at the 5' end and
polyadenylated at the 3' end (Yogo et al., 1977; Lai and Stahlman, 1978). In
MHV, the viral RNA contains 8 genes and is about 31 kilobases in length,
thus making it the largest viral RNA genome identified to date (Pachuk et

al., 1989; Lee et al., 1991). The virion RNA itself carries all the genetic
information for coronavirus replication and is infectious when it is
transfected into eukaryotic cells (Wege et al., 1978).

Coronavirus replication occurs exclusively in the cytoplasm of the
infected cells (Brayton et al., 1981; Wilhelmsen et al., 1981). Upon viral
infection, virions use the spike proteins to attach to the receptors on the
surface of the target cell and penetrate the cell by immediate membrane
fusion or endocytosis. When viral genomic RNA is released into the host
cell cytoplasm, the first event is the translation of the viral specific RNAdependent RNA polymerase from the incoming genome. Using the genome
as the template, this polymerase transcribes a genomic-length negativestrand RNA, which in turn serves as the template for the transcription of
genomic RNA and seven subgenomic viral messenger RNAs.

These

mRNAs have the same 3' end, extend in the 5' direction for various lengths
and contain an identical leader sequence (approximately 72 nucleotides) at
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the 5 1 end (Lai and Stohlman, 1978; 1981; Lai et al., 1981; 1982a; 1983; Spaan

et al., 1983). For each of these nested-set mRNAs, only the 5' most gene is
translated into viral proteins (Siddell et al., 1983). For instance, although
the genomic mRNA contains a total of 8 genes, only gene 1 at its 5' end is
translated which results in the synthesis of the polymerase (Leibowitz et

al., 1982b; Denison and Perlman, 1986). Following protein synthesis and
viral replication, virions are assembled in the rough endoplasmic
reticulum of the cytoplasm and bud out of the cell.

Thus, like many

positive-strand RNA viruses, coronavirus RNA is infectious and the viral
replication cycle takes place in the cytoplasm of the infected cell.

Two unique features have been observed during coronavirus
replication: (1) discontinuous transcription and (2) high frequency RNA
recombination.

The identical leader sequence (approximately 72

nucleotides) at the 5' end of the seven subgenomic RNAs is derived from the
5' end of the genomic RNA by a discontinuous transcription mechanism
(Barie et al., 1983; Spaan et al., 1983; Lai et al., 1983; 1984; Makino et al.,
1986b; 1988; 1989; Baker and Lai, 1990). For this unique discontinuous
transcription, several models have been proposed, among which "leaderprimed" transcription is the most favored and has been supported by a
large body of evidence (Barie et al., 1983; Spaan et al., 1983; Lai et al., 1983;
1984; Makino et al., 1986b; 1988; 1989; Baker and Lai, 1990). According to
this model (Fig. 1), free leader RNAs (approximately 72 nucleotides) are
synthesized from the negative RNA template during coronavirus
replication.

These leader RNAs disassociate from

~he

template and
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Fig. 1. Model of "leader-primed" transcription of coronavirus mRNAs. A.
"Leader-primed" transcription in the coronavirus RNA replication cycle.
The viral genomic RNA (+) released in the infected cell is first used to
synthesize the viral specific RNA-dependent RNA polymerase.

This

polymerase transcribes a genomic-length negative RNA (-) from the viral
genomic RNA (+) and uses it as the template for the replication of a nestedset genomic and subgenomic mRNAs (+) shown below.

A nested-set

subgenomic negative RNAs (-)are also indicated as the potential templates
for the transcription of the subgenomic mRNAs (+). The solid squares
represent leader RNA. B. An example of the intergenic sequences. Partial
sequences of a free leader RNA is denoted above the template of a genomiclength negative RNA. The intergenic sequence preceding gene 6 is shown
to be hybridized to the free leader RNA by homologous sequences. The
arrow indicates the consensus sequence UCUAAC in the leader RNA.
(The figure was modified from Lai, 1990).
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rehybridize to the homologous sequence (several repeats of AGAUU) in the
region between each gene. The leader RNA serves as a primer for the
transcription of each of the seven subgenomic mRNAs. Transcription of
these subgenomic mRNAs initiates at different intergenic sites and extends
to the 3' end along the negative RNA template. This results in a nested-set
structure of these genomic and subgenomic mRNAs.

The second unique feature, high frequency RNA recombination, was
observed during mixed infection of different coronaviruses (Keck et al.,
1987; 1988a; 1988b; Makino et al., 1986b; 1987). In the mixed infection, viral
RNA transcription intermediates may dissociate from one template to bind
to another viral template at the homologous sequence and be incorporated
into genomic RNA in the subsequent RNA replication.

The complex viral transcription and replication strategy of
coronavirus indicates a viral RNA polymerase with unusual properties.

Murine coronavirus polymerase polyprotein

The coronavirus encoded RNA polymerase is known to be
responsible for replication of the viral negative RNA, synthesis of genomic ·
and subgenomic RNAs, and replication of virion RNA (Brayton et al., 1982;
1984; Lai et al., 1982b; Leibowitz et al., 1982a). In addition, coronavirus
polymerase is also known to transcribe the small leader RNAs which have
been detected in the coronavirus infected cells (Lai et al., 1983; 1984; Barie et
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al., 1983). To better understand the functional activities of coronavirus
polymerase, we must elucidate the mechanism of MHV RNA polymerase
expression and processing.

The murine coronavirus RNA polymerase is encoded by the 5' most
gene of the virion RNA, termed gene 1.

Gene 1 has been completely

sequenced for coronavirus IBV (Bournell et al., 1987), MHV-JHM (Lee et

al., 1991), MHV-A59 (Pachuk et al., 1989; Bredenbeek et al., 1990; Bonilla et
al., 1994) and HCV (Herold et al., 1993). In the MHV-JHM virus strain,
gene 1 is 22 kb in length and encompasses about two thirds of the entire
viral genome (Lee et al., 1991).

This gene is known to contain two

overlapping open reading frames designated ORFla (13 kb) and ORFlb (9
kb) which can be translated into a single polyprotein greater than 750 kDa
via a ribosomal frameshifting mechanism (Brierly et al., 1987; 1989;
Bredenbeek et al., 1990; Lee et al., 1991). Computer analysis of the deduced
amino acid sequence of this large polymerase polyprotein suggests diverse
functional domains, such as a polymerase motif, a helicase domain, a zincfinger motif in ORFlb, transmembrane regions, cysteine-rich domains,
and three proteinase domains in ORFla (Gorbalenya et al., 1989; 1991;
Bredenbeek et al., 1990; Lee et al., 1991) (see Fig. 2). The three proposed
proteinase domains, two papain-like cysteine proteinases (PCP-1 and PCP- ·
2) and a poliovirus 3C-like serine proteinase (3C-Pro), are approximately
3.5-4.2 kb, 5.3-6.l kb, and 10.2-10.9 kb from the 5' end of the gene 1
respectively (Lee et al., 1991). The large size of the polymerase polyprotein
and the presence of potentially active proteinase domains suggest that the

8

Fig. 2. Schematic diagram of murine coronavirus gene 1 and its putative
functional domains.

(The figure was modified from Lee et al., 1991).
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putative polymerase polyprotein undergoes extensive proteolytic processing

to release multiple mature and functional protein products.

Prote<>]ytic processing of the murine coronavirus polymerase polyprotein

Since gene 1 is expressed at a very low level and coronavirus does not
inhibit host cell protein synthesis efficiently, it is very difficult to investigate
viral gene expression in vivo without specific antibodies. Early studies of
gene 1 translation products were mainly done in the rabbit reticulocyte
lysate (RRL) cell free protein-synthesizing system (Leibowitz et al., 1982b;
Denison and Perlman, 1986).

The first protein to be identified as a

proteolytic processing product of the polymerase polyprotein was a 28 kDa
protein, designated p28. Denison and Perlman (1986) demonstrated that in

vitro translation of MHV-A59 genomic RNA isolated from virus-infected
cells produced two prominent proteins, p28 and p220 (Denison and
Perlman, 1986). The appearance of p28 could be inhibited by the addition of
the proteinase inhibitor ZnCl2, suggesting that p28 was processed from a
precursor polyprotein (Denison and Perlman, 1986). p28 was shown to be
the N-terminal peptide processed from the gene 1 polyprotein and also
detected in MHV infected cells (Denison and Perlman, 1986; 1987). By in

vitro T7 RNA polymerase transcription and in vitro translation in rabbit ·
reticulocyte lysates of a plasmid containing the 5'-end 2 kb cDNA of gene 1,
p28 was confirmed as the amino-terminal portion of the putative
polymerase polyprotein (Soe et al., 1987). Furthermore, by translating
RNAs which represented up to 5.3 kb of the 5'-end of the MHV genome,
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Baker et al. showed that the processing of p28 was an autoproteolytic event
in which a downstream sequence about 4 kb from the 5' end of gene 1 was
required for the cleavage of p28 (Baker et al., 1989). Significantly, this
region overlaps with the first papain-like cysteine proteinase (PCP-1)
domain predicted from sequence analysis (Gorbalenya et al., 1991, Lee et

al., 1991), suggesting that PCP-1 is the proteinase which cleaves the p28
protein.

In addition to p28, several other protein products ranging from 50
kDa to 290 kDa in size have been detected from the in vitro translation of
MHV genomic RNA or in the infected cells using antiserum directed
against viral peptides or fusion proteins (Denison et al., 1991; 1992).
However, the proteinases responsible for their processing are largely
unknown. Our knowledge of how these proteins are processed from the
polymerase polyprotein and the relationships between them is also
incomplete. Currently, the first papain-like cysteine proteinase (PCP-1) is
the only proteinase domain among the three proposed proteinases whose
activity has been directly demonstrated (Baker et al., 1989). Although the
only known function of PCP-1 is to mediate a cis-cleavage of p28, it is highly
possible that PCP-1 cleaves at additional sites in the coronavirus
polymerase polyprotein.

The study of p28 processing will enrich our

knowledge of proteolytic processing of the polymerase polyprotein and help
to predict additional processing events.
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The proteolytic processing of the polymerase polyprotein may play an
important role in regulating viral replication, as has been shown in several
other viruses such as poliovirus and Sindbis virus (Dewalt and Semler,
1987; Lemm and Rice, 1993; Shirako and Strauss, 1994).

In addition,

proteolytic processing may activate diverse functions of the polymerase
polyprotein by inducing conformational changes.

In terms of the

understanding of how coronavirus polymerase works, it is possible that the
polymerase polyprotein undergoes proteolytic cleavages at several sites to
release multiple functional units.

The functional subunits may still

associate together as a working complex for coronaviral RNA replication.
Understanding the proteolytic processing of gene 1 may ultimately help us
to identify individual polymerase subunits and to understand their
functions. Additionally, viral proteinases are potential targets for specific
antiviral agents since viral replication can be interrupted by inhibiting the
essential proteolytic processing events to inactivate fundamental enzymes
for viral replication.

Such work has already begun for human

immunodeficiency virus (HIV), and results suggest that intervention with
proteinase inhibitors may become a successful treatment for Acquired
Immune Deficiency Syndrome (AIDS) (McQuade et al., 1990).

The goal of this Ph.D. dissertation research is to study proteolytic
processing of the murine coronavirus polymerase polyprotein, especially
focusing on the p28 processing event.

Previous studies lead to the

hypothesis that the MHV PCP-1 proteinase domain, which acts to cleave at
the amino terminal region of polymerase polyprotein to release p28,
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probably belongs to the family of cysteine proteinases (with plant proteinase
papain as the prototype). The following questions were addressed in this
research:

1) What are the catalytic residues of MHV PCP-1?

2) What is

the cleavage site recognized by MHV PCP-1 to release p28?

To address these questions, I have used the well developed T7 RNA
polymerase transcription/RRL translation system to express a variety of
mutant polyproteins, and I have assayed the effect of these mutations on
proteolytic processing of p28. I have characterized the proteinase activity
and the catalytic sites, showing that PCP-1 is a new member of the family of
papain-like cysteine proteinases.

Additionally, I have identified the

cleavage site by partial N-terminal protein sequencing, and defined the
recognition motif of the cleavage site by site-directed mutagenesis.

CHAPrERD
MATERIALS AND METHODS

p]aSJDid DNA

A T7 RNA polymerase transcription plasmid pT7-NBgl, which
contains the MHV-JHM genomic cDNA sequence from nucleotide 187 (Nar
I site) to 5273 (Bgl II site), and its deletion plasmids pT7-NAc, pT7-N27 and
pT7-N29 have been previously described (see Fig. 3, Baker et al., 1989; 1993).
pT7-NAc is derived from pT7-NBgl with a deletion from nucleotide 4434
(Ace I site) to 5273 (Bgl II site). pT7-N27 is derived from pT7-NAc with a
deletion from nucleotide 2068 (Nsi I site) to 2811 (Kpn I site ). T7-N29 is
derived from pT7-NAc with deletion from nucleotide 1167 (SnaB I site) to
2811 (Kpn I site).

Plasmid DNA preparation

Large scale preparations and minipreparations of plasmid DNAs
were isolated by the alkaline lysis method basically as described by Maniatis

et al. (1982). For large scale plasmid preparation, a single colony was
inoculated into 5 ml Luria broth (LB, lOg/l bacto-tryptone, 5g/l bacto-yeast
extract and lOg/1 NaCl, pH 7.0) with 50 mg/ml ampicillin (Amp) and grown
for 5-6 hours at 37oc with vigorous shaking (250 rpm). Two and one half ml
of this small culture was inoculated into 250 ml LB/Amp (50 µg/ml) and
incubated with shaking for 14-16 hours at 37oc.
14

The bacteria were
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Fig 3.

Schematic diagram of corresponding gene 1 sequence in the

plasmids of pT7-NBgl family. A partial restriction map of the 5'-end 5.3 kb
of MHV-JHM genomic cDNA is shown to scale (Nar 1:187, SnaB 1:1167, Nsi
1:2068, Kpn 1:2811, Ace 1:4434, Bgl 11:5273). The translation initiation codon
(AUG) is at nucleotide 215. The p28 region, which is released by the
autoproteinase activity, is denoted by the stippled box. The putative first
papain-like cysteine proteinase (PCP-1) domain is indicated by the hatched
box. The putative p28 cleavage site at approximately 1 kb from the 5' end is
indicated by an arrow. The sizes of encoded precursor polyprotein and
potential processed products are indicated in the parenthesis.
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harvested by centrifugation at 7 k rpm for 10 min at 4oc in a Sorvall GSA
rotor. The pellet was resuspended in 4 ml of solution I (50 mM glucose, 100
mM EDTA, 28 mM Tris-HCl, pH 8.0) and incubated for 15 min at room
temperature. Bacteria were lysed by adding 7.5 ml of solution II (0.2 N
NaOH, 1% SDS, freshly made from 10 N NaOH and 10% SDS), and
incubated for 10 min on ice. The cell lysates were neutralized by adding 6
ml of solution III (5 M KOAc, pH 4.8) and inverting the tubes and incubated
for 10 min on ice. The cell debris was pelleted by centrifugation for 30 min
at 12 k rpm at 4oc in a Sorvall SS34 rotor. The supernatant (about 16 ml)
was transferred to a Corex tube (30 ml capacity), mixed with 0.6 volume (11
ml) of isopropanol and incubated for 15 min at room temperature. The
nucleic acids were pelleted by centrifugation for 10 min at 10 k rpm in a
Sorvall SS34 rotor and the pellet was dried in a Savant Speed Vac. This
nucleic acid pellet was resuspended in 8 ml of TE buffer (10 mM Tris-HCl, 1
mM EDTA, pH 8.0) and treated with 40 µl RNase A (10 mg/ml stock
solution) for 30 min at 42oc to degrade tRNA (transfer RNA).

The

supercoiled plasmid DNA was purified by equilibrium centrifugation in
cesium chloride (CsCl) ethidium bromide gradients. For each ml of DNA
solution, 1 g of solid CsCl was added and the final density of the solution
should be 1.55 g/ml (refractive index= 1.3860). When the salt is completely
dissolved, 250 µl ethidium bromide (10 mg/ml stock solution, final ·
concentration 312.5 µg/ml) was added. The mixed sample was centrifuged
for 14-16 hours at 55 k rpm in a Beckman VTi 65 rotor. The band of the
supercoiled plasmid DNA was collected by side puncture with a 16 gauge
needle. The ethidium bromide was removed from the DNA by repeated
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extraction with an equal volume of deionized water-saturated butanol until
the pink color disappeared. The CsCl was removed by overnight dialysis at
40C with at least two changes of 0.5 X TE buffer. Finally, the DNA solution
was collected and stored at 4oc. The yield and purity of plasmid DNA was
determined by measuring OD at 260 nm and OD at 280 nm in a UV
spectrophotometer. The plasmid DNA was analyzed by electrophoresis in a
1% agarose gel. The DNA (0.2 µg) was diluted in 6 X loading buffer (0.25%

bromophenol blue, 0.25% xylene cyanol FF and 30% glycerol) and loaded
onto a 1% mini-agarose gel prepared in 1 X TBE buffer (89 mM Tris-HCl, 89
mM boric acid, 2 mM EDTA, pH 8.0) containing 0.5 µg/ml ethidium.
bromide. The DNA was analyzed by electrophoresis at 100 Volts (V) for 30
min. Lambda DNA digested with Hind III (Gibco BRL) was loaded as the
size marker.

Minipreparations of plasmid DNA were carried out using the
Magic™ Minipreps DNA Purification System (Promega) following the
manufacturer's instructions.

Briefly, 3-5 ml of the overnight cultured

bacteria cells were pelleted in an Eppendorf microcentrifuge (1 min at high
speed) and the pellet was resuspended in 200 µl of Cell Resuspension
Solution (Sm mM Tris-HCl, pH 7.5, 10 mM EDTA, pH 8.0, 100 µg/ml RNase
A). The cells were lysed by adding 200 µl of Cell Lysis Solution (0.2 M ·
NaOH, 1% SDS) and inverting the tube several times. To the cell lysates,
200

µ:1 of Neutralization Solution (2.55 M KOAc, pH 4.8) was added and

mixed by inverting the tubes. After centrifugation for 5 min at 12,000 X g,
the supernatant was transferred to another tube and mixed with 1 ml of the
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in 5 mM EDTA and 0.5% SDS for 30 min at 56°C to digest the restriction

enzymes. The final volume was brought up to 200 µl with dH20 and the
linearized plasmid DNA was extracted with an equal volume of
phenol:chloroform

(1:1)

once

and

chloroform:isoamyl alcohol (24:1) once.

then

an

equal

volume

of

Eight µl of 5 M NaCl (final

concentration 200 mM) and 2.5 volume of ethanol were added to the
supernatant and mixed by vortexing. The mixture was frozen at -700C for
20 min and centrifuged for 10 min at 12,000 X g to precipitate DNA. The
DNA pellet was gently rinsed with 1 ml of cold 70% ethanol and dried in a
Savant Speed Vac. The final DNA pellet was resuspended in 20 µl of DEPCdH20 (diethyl pyrocarbonate treated nuclease-free water) and 2 µl was
removed for analysis by electrophoresis on a 1% mini-agarose gel as
described above.

In vitro T7 RNA polymerase transcription
Plasmid DNA was transcribed in vitro with a T7 RNA polymerase
(Promega) specific for a T7 promoter (Tabor and Richardson, 1985). The
transcription reaction was performed in a total volume of 50 µl with 1 µg of
linearized plasmid DNA in 40 mM Tris-HCl (pH 7 .9), 6 mM MgCl2, 10 mM
DTT (dithiothreitol), 2 mM spermidine, 10 mM NaCl, 0.5 mM of ATP, CTP,
and UTP, 0.05 mM GTP, 0.25 mM m7G(5')ppp(5')G cap analog (NEB), 10 u
of T7 RNA polymerase (Promega), and 40 u of RNasin ribonuclease
inhibitor (Promega) and DEPC-dH20 at 37oc for 1 hour (Baker et al. 1989;
1993). The reaction mixture was treated with 2 u of RQI DN ase (Promega)
at 37oc for 30 min to degrade the DNA template. The final volume was
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brought up to 200 µI with DEPC-H20 and extracted with an equal volume of
phenol:chloroform (1: 1) and then an equal volume of chloroform:isoamyl
alcohol (24:1).

The upper aqueous phase was transferred to a sterile

microcentrifuge tube and mixed with 0.1 volume of 3M NaOAc and 2.5
volume of ethanol and cooled to -700C for 20 min.

The mixture was

centrifuged at 12,000 X g for 10 min. The pellet (normally milky white) was
gently rinsed with 1 ml of cold 70% ethanol, dried and resuspended in 100 µl
DEPC-H20. The resuspension solution was mixed with 100 µl 5M NH40Ac
(final concentration 2.5 M) and 2.5 volumes of ethanol and frozen for 20 min
at -700C. This second precipitation removes free nucleotides. The final
pellet was gently rinsed in cold 70% ethanol, dried in a Savant Speed Vac
and resuspended in 20 µl of DEPC-dH20. The yield was quantitated by
measuring OD at 260 nm in a UV spectrophotometer. Two µl of RNA was
diluted in 6 X loading buffer and analyzed in a 1.2% agarose gel (prepared
in filtered 1 X TBE buffer containing 0.1-0.5 µg/ml ethidium bromide) at 60
V for 1-2 hour(s) (See Fig. 4).

Lambda DNA Hind III fragments were

loaded as the size marker. The remaining RNA was stored at -700C until
future use.

In vitro translation in rabbit reticulocyt.e lysates
Translation of in vitro transcribed RNA by T7 RNA polymerase was
performed in the nuclease treated rabbit reticulocyte lysates following
manufacturer's suggestion (Promega). Two hundred ng of purified RNA
transcripts were mixed with 10 µl of the nuclease treated rabbit reticulocyte
lysates, 1 µl of 1 mM amino acid mixture (minus Met) and 2 µl of 35S-Met
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Fig. 4. Agarose gel electrophoresis analysis of the in vitro transcribed pT7N27 RNA. Plasmid pT7-N27 linearized with EcoR I was transcribed by a T7
RNA polymerase from a specific T7 promoter as described in the Materials
and Methods. RNA from four standard reactions was combined and 2 µl
RNA (approximately 200 ng) was analyzed by electrophoresis in a 1.2%
agarose gel and visualized by staining with ethidium bromide. Lambda
DNA digested with Hind III was used as the size marker.
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'1,000 µCi/ml, Amersham) or Trans 35S-label (1,000 µCi/ml with 70% 35g_
(

r Met and 15% 35S-Cys, ICN) and DEPC-dH20 in a final volume of 25 µl and

incubated for 90 min at aooc. One to two µl of the reaction was diluted in 10

,u of 2 X Laemmli Sample Buffer (10% glycerol, 5% fi-mercaptoethanol,

3%

SDS, 80 mM Tris-HCl, pH 6.8, and 1 µg/ml bromophenol blue) (Laemmli,
1970) and analyzed by electrophoresis in 10% polyacrylamide gel containing
0.1% SDS. The remainder of the translation reaction was stored at -700C.

Coupled in vitro transcription and trans1ation
Linearized plasmid DNA template was transcribed with T7 RNA
polymerase and translated in rabbit reticulocyte lysates in a coupled
transcription translation system (TNT lysates, Promega) following the
manufacturer's protocol. For a standard reaction, approximately 0.5 µg of
linearized plasmid DNA was incubated with 12.5 µl TNT rabbit reticulocyte
lysate, 1 µl TNT reaction buffer, 0.5 µl T7 RNA polymerase (Promega), 20 u
RN asin ribonuclease inhibitor (Promega), 1 µl of 1 mM Met-free amino acid
mixture, and 2 µl of 35_8-Met (1,000 µCi/ml, Amersham) or Trans 35S-label
(1,000 µCi/ml, 70% 35S-Met and 15% 35S-Cys, ICN) and DEPC-dH20 in a
final volume of 25 µl for 90 min at aooc. Two µl of the reaction were
removed and precipitated by trichloroacetic acid (TCA) to measure
incorporation of radioactivity. One to two µl of the reaction was analyzed by
electrophoresis in a 10% SDS polyacrylamide gel and the remainder was
stored at -700C.
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TCA precipitation assay to determine incorporation of radioactivity in the
in vitro translated prot.ein product

The incorporation of radioactivity into the protein products of an in

vitro translation was measured by a trichloroacetic acid (TCA) precipitation
assay (Sambrook et al., 1989). The simplified protocol for TCA protein
precipitation assay was from Dr. Tom Gallagher (Loyola University of
Chicago).

Individual Whatman 3MM filter paper disks (2-2.3 cm in

diameter) were spotted with 100 µl of Solution A [3% CAA (casamino acids,
as a protein carrier), 1% SDS] and air-dried for 0.5-1 hour. Two µl of the
translation reaction was loaded at the center of the filter disk and air-dried
for 10 min. Two µl from an in vitro translation reaction containing no
mRNA was spotted onto a filter paper disc as a control to determine the
background incorporation. The sample-loaded filters were transferred into
a capped plastic tube (50 ml capacity, 4-6 filters per tube) and washed in 45
ml of Solution B (10% TCA, 3% CAA, 1% SDS) by slow shaking in an orbital
shaker for 30 min at room temperature. Solution B and all other used
solutions containing radioactivity were carefully discarded into a
radioactive liquid disposal container. Forty-five ml of Solution C (5% TCA,
1.5% CAA) was added and incubated in an 850C shaking water bath for 20
min. The filters were washed twice for 5 min with 45 ml of 5% TCA and
then 45 ml of 95% ethanol. The filters were rinsed twice with dH20 and airdried for 0.5-1 hour. Each dried filter was transferred to a 5 ml plastic
scintillation vial with 4 ml of biodegradable counting cocktail Econo-Safe™
(Research Products International Corp.) and counted in a Beckman LS 5801
scintillation counter using the USER 2 program. The net incorporation of
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radioactivity in the synthesized protein of each translation reaction was
calculated by subtracting background from the cpm (count per min).

Anti-p28 serum and radioimmunoprecipitation
Polyclonal anti-p28 serum was generated in a rabbit against a
eynthetic peptide representing amino acids 78 to 93 (NH3-R-D-I-F-V-D-E-DP-Q-K-V-E-A-S-T-COOH) of the p28 protein (previously prepared in our
laboratory, Baker et al., 1989). One and one half g of Protein A-Sepharose
CL-4B beads (Pharmacia) were swollen in 15 ml of dH20 and washed 2-3
times in PBS buffer (8 g/l of NaCl, 0.2 g/l KCl, 1.44 g/l Na2HP04 and 0.24 g/l
KH2P04) to remove any additives and stored at 4oc for future use. To avoid
the loss of beads during washing, the bead suspension can be briefly
centrifuged after each step. The desired amount of beads were removed
prior to each use. The beads were spun down, washed once in RIPA buffer
(0.5% Triton X-100, 0.1% SDS, 300 mM NaCl, 4 mM EDTA and 50 mM TrisHCl) and resuspended 1:1 in RIPA buffer.

Samples of the in vitro

translation reaction containing equivalent amount of TOA-precipitable
radioactivity (10-15 µl, 0.5-5 X 105 cpm) were incubated with 3 µl of anti-p28
serum in 1 ml of RIPA buffer in a safe-lock microcentrifuge tube with headto-tail rotation at 4oc. Thirty µl of a 1:1 suspension of Protein A-Sepharose
beads in RIPA buffer was added and the incubation reaction was continued
for an additional 4 hours at 4oc. The beads were pelleted by a brief (1-2 min)
microcentrifugation and washed three times with 1 ml of RIPA buffer. The
washed beads were suspended in 50 µl of 2 x Laemmli sample buffer,
heated at 10000 for 2 min, and microcentrifuged for 5 min.

The
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supernatant was loaded on a 10% polyacrylamide gel containing 0.1 % SDS
(SDS-PAGE) for electrophoresis.

polyacrylamide gel electrophoresis and autoradiograpby
Direct in vitro translation products or the immunoprecipitated
proteins of in vitro translation were analyzed by polyacrylamide gel
electrophoresis as described by Maizel, 1971. A 10% acrylamide, 0.1% SDS
discontinuous gel was prepared in a Hoefer SE 600 Vertical Slab Unit.
Twenty ml of 10% resolving gel was prepared by mixing 8.4 ml of dH20, 5.0
ml of 4 X Lower Buffer (181.7 g/l Tris-base, 0.4% SDS, pH 8.8), 6.6 ml of
30:0.8% Acrylamide:N, N'-methylene-bisacrylamide, 60 µl of 10% APS
(ammonium

persulfate)

and

7.5

µl of TEMED (N, N, N', N'-

tetramethylethyl-enediamine). For 10 ml of 5% stacking gel, 6.65 ml of
dH20, 1 ml of 50% glycerol, 1.30 ml of 4 X Upper Buffer (60.6 g/l, 0.4% SDS,
pH 6.8), 1.10 ml of 30:0.8% acrylamide:N, N'-methylenebisacrylamide, 75 µl
10% APS, and 20 µl of TEMED were mixed together. The gel was run in the
1 X Running Buffer (12.0 g/l, Tris-base, 57.6 g/l glycine, 0.1% SDS) at
constant volts (50-200 V) until the bromophenol blue dye reached the bottom
of the gel. Following electrophoresis, the gel was removed and fixed for 3060 min in 40% methanol-7% acetic acid solution with gentle shaking in an
orbital shaker. After fixing, the gel was enhanced for 1.5 hours with Du·
Pont Entensify, dried and exposed to Kodak X-ray film at -700C.
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p,oteinase inhibition assay

The proteinase inhibition assay was performed using pT7-N27 RNA
(see Fig. 4) in rabbit reticulocyte lysates in the presence of a variety of
proteinase inhibitors. The proteinase inhibitors tested include a general
inhibitor ZnCl2, four cysteine proteinase inhibitors: cystatin (Boehringer
Mannheim Biochemica, BMB), Iodoacetamide (Sigma), N-ethyl-maleimide
(Sigma) and E-64 (BMB), a cysteine and serine proteinase inhibitor
leupeptin (BMB), a serine proteinase inhibitor APMSF [94-(amidinophenyl)methanesulfonylfluoride, BMB], an aspartic proteinase inhibitor pepstatin
A

(BMB),

and

a

metallo-proteinase

inhibitor

EGTA

{[ethylenebis(oxyethlenenitrilo)]-tetraacetic acid, BMB}. Large quantities of
RNA were synthesized in vitro as described in the in vitro transcription
reaction. Four standard in vitro transcription reactions (50 µl) were set up
and the final products of each reaction were resuspended in 20 µl of dH20
and combined together to quantitate the concentration and yield of the RNA
synthesized. The same amount of homogenized RNA (approx. 200 ng) was
used in each translation reaction as described in the in vitro translation
reaction in rabbit reticulocyte lysates. The proteinase inhibitor was added
to the translation reaction (25 µl, final volume) prior to the incubation at
300C and the translation reaction was carried out for 90 min.

The

translation products were analyzed by electrophoresis in a 10% SDS- ·
polyacrylamide gel and autoradiography. The radioactivity of p28 (with 7
Met) and the precursor polyprotein (with 37 Met) was quantitated in a
Betagen scanner. The efficiency of p28 processing was calculated after
normalizing the differences in Met contents in the following formula: 37 X
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[p28] / { 37 X [p28] + 7 X [precursor]}. The percentage of the inhibition was
measured by comparing the decrease of p28 processing efficiency in the
translation reaction with proteinase inhibitors to that without proteinase
inhibitors. A wide range of concentrations of each inhibitor was tested to
achieve an optimal working concentration.

The optimal concentration

produced significant inhibition of p28 processing but had no effect on the
overall efficiency of translation reactions.

Purification of DNA from low-melting agarose gels
Low-melting agarose gel (SeaKem, FMC) with 1 cm wide wells were
prepared in 1 X TAE (40 mM Tris-acetate, 1 mM EDTA) containing 0.1
µg/ml ethidium bromide. Restriction enzyme digested plasmid DNA was
loaded onto the gel, fragments were separated by electrophoresis at 60 V for
3-4 hours and visualized on an ultraviolet light transilluminator. The
specific DNA bands of interest were identified according the DNA marker
(lambda DNA digested with Hind III fragments, Gibco BRL) and excised
from the gel with a razor blade. The agarose gel slice containing DNA was
submerged in 3 volume of TE buffer in one (or several) microcentrifuge
tube(s) and heated at

1ooc for

2-5 min in a heating block. The melted

agarose solution was homogenized by briefly vortexing and quickly frozen
in a dry-ice ethanol bath (-700C) for 5-10 min. The mixture was thawed by·
tapping the tube vigorously against the lab bench. The solidified agarose
beads were removed by centrifugation for 1-5 min. The agarose-free DNA
in the supernatant was extracted with equal volumes of phenol:chloroform
and chloroform:isoamyl alcohol and concentrated by ethanol precipitation.
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The DNA pellet was washed with cold 70% ethanol and resuspended in 20
µl of TE buffer.

Construction of plasmid pS-N27
For site-directed mutagenesis, the MHV-JHM gene 1 sequence in
pT7-N27 was inserted into plasmid pSELECT-1 (Altered Sites in vitro
Mutagenesis System, Promega) to create a new recombinant plasmid pSN27 (see Fig. 5). pSELECT-1 (Amps and Teer), a hybrid of pBR322 and
pGEM-3Zf{+), carries modified ampicillin gene (4 base frameshifting), a
tetracycline resistance gene, a fl replication origin and a polylinker region
(Lewis and Thompson, 1990).

Plasmid pT7-N27 contains MHV-JHM

genomic cDNA sequence from nucleotide 187 to nucleotide 4434 with a 747
nucleotide deletion of nucleotide 2064-2810 under the control of a T7
promoter. This 3.5 kb region of gene 1 (with a translation start codon at
nucleotide 215) has a capacity to encode a 128 kDa precursor polyprotein
which is expected to autoproteolytically release p28 and a 100 kDa Cterminal protein (Baker et al. , 1993). Four µg of pT7-N27 was digested by
Pvu II (upstream of the T7 promoter) and EcoR I (just downstream of the
MHV-JHM region) in a volume of 200 µI. Five µg of pSELECT-1 was
digested by Sma I and EcoR I (Both sites are located within the polylinker
region) in a reaction of 200 µl. Completion of each digestion was checked by
electrophoresis in a 1% agarose gel. The double digested pSELECT-1 DNA
was extracted with equal volumes of phenol:chloroform (1: 1) and
chloroform:isoamyl alcohol (24:1) and concentrated by ethanol
precipitation.

The resuspended pSELECT-1/Sma l/EcoR I DNA was
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Fig. 5. Schematic diagram of MHV-JHM gene 1 cDNA in plasmid pS-N27
and its encoded polypeptide and autoproteolytically processed proteins. The
MHV-JHM gene 1 cDNA from an in-frame deletion construct, pT7-N27,
was inserted into plasmid pSELECT-1 as described in the Materials and
Methods. The new recombinant plasmid was named as pS-N27 (A). This
3.5 kb gene 1 clone, containing nucleotides from 187 (Nar I site) to 2063 (Nsi
I site) and nucleotides from 2811 (Kpn I site) to 4431 (Ace I site), is the
smallest deletion clone which still maintains active proteolytic processing
of p28. The two overlapping reading frames (ORF) are shown at the top
with only ORFla drawn to scale. The three proposed proteinase domains
(Lee et al., 1991) are indicated, among which PCP-1 (hatched box, between
3.5-4.2 kb) has been demonstrated to be active (Baker et al., 1989). Proteolytic
processing of the polypeptide translated from RNA derived from plasmid
pS-N27 (also pT7-N27) is shown at the bottom (B). The precursor polypeptide
(128 kDa) synthesized from linearized pS-N27 (also pT7-N27) in the in vitro
T7 RNA polymerase transcription and rabbit reticulocyte lysate translation
system is autoproteolytically processed to two products: N-terminal p28 and
C-terminal peptide (100 kDa) (Baker et al., 1993). The p28 region is
indicated by the stippled box and PCP-1 domain by the hatched box. The
arrow represents the putative cleavage site of p28.
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further de-phosphorylated by calf intestinal alkaline phosphatase (CIP,
BRL) in 1 mM ZnCl2, lmM MgCl2, and 10 mM Tris-HCl, pH 8.3. CIP was
removed by protease K treatment in 5 mM EDTA and 0.5 % SDS, and
extracted with equal volumes of phenol:chloroform (1:1)
chloroform:isoamyl alcohol (24:1).

and

The double digested pT7-N27 and

pSELECT-1 (de-phosphorylated) were respectively separated by
electrophoresis in a 1.2% or 0.8% low-melting agarose gel. The insert (a 3.5
kb DNA fragment of pT-N27) and the vector (a 5.6 kb DNA fragment of
pSELECT-1) were purified from the low-melting agarose gels by the freeze
and thaw method as described above. The gel purified fragments were
ligated in a volume of 10-20 µl with 1 u ofT4 DNA ligase (BRL), 50 mM TrisHCl pH 7.6, 10 mM MgCl2, 1 mM ATP and 1 mM DTT at 14oc for 8-16
hours. The control for the ligation reaction contained only CIP-treated
vector but no insert. An E. coli DH5a strain was transformed by the
ligation reaction and spread on a LB plate containing tetracycline (15
µg/ml), X-Gal

(5-bromo-4-chloro-3-indolyl-~-D-galactoside,

per plate) and IPTG

(isopropylthio-~-D-galactoside,

40 µl of 20 mg/ml

4 µl of 200 mg/ml per

plate). Only the white colonies were isolated to screen the recombinant
plasmid, and the recombinant plasmid pS-N27 was confirmed by restriction
enzyme digestion.

Single-strand phagemid DNA preparation
Phagemid pS-N27 containing a fl origin (which is derived from a
filamentous bacteriophage) can replicate in a single strand form in E. coli
strain JM109 after infection with helper phage R408 (Vieira and Messing,
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1987; Maniatis et al., 1982). JM109 were transformed with p8-N27 and
spread on a minimal plate {3g/l KH2P04, 7 g/l K2HP04, 2 g/l (NH4)2804, 0.5
mg/l Fe804, 10 mM Mg804, 0.05 mg/l thiamine, and 4% glucose)
containing tetracycline (15 µg/ml) to ensure the presence of bacterial Fl pill
for bacteriophage infection. A single tetracycline-resistant colony of JM109
containing p8-N27 plasmid was inoculated in 5 ml of TYP broth (16 g/l
Bacto-tryptone, 16 g/l Bacto-yeast extract, 5 g/l NaCl and 2.5 g/l K2HP04)
with 15 µg/ml tetracycline in a 50 ml tube to prepare an overnight culture.
Two hundred µl of the overnight culture was inoculated into 5 ml of TYP
broth containing 15 µg/ml tetracycline in a 125 ml flask with vigorous
shaking for 30 min at 37oc. The culture was infected with helper phage
R408 at an m.o.i. (multiplicity of infection) of 10 (40 µl of the stock from
Promega, >1 X 1011 plaque forming unit per ml or pfu/ml) and shaken for
additional 6-8 hours. The bacteria were pelleted by centrifugation twice at
10 k rpm for 5 min at 40C in a 8orvall 8834 rotor.

The supernatant

containing the secreted phage particles was transferred to a Corex tube (15
ml), mixed gently with 1/4 volume of phage precipitation solution (3.75 M
NH40Ac and 20% PEG) and incubated on ice for 15-30 min. The mixture
was centrifuged at 10 k rpm for 15 min at 4oc. The pellet was drained
thoroughly and then resuspended in 400 µl of TE buffer. The suspended
solution was transferred to a microcentrifuge tube and extracted by equal
volumes of chloroform (first, to lyse the phage particles), phenol:chloroform
(1:1, twice), and then chloroform:isoamyl alcohol (24:1). The upper aqueous
phase was transferred to sterile microfuge tubes and mixed with 0.5
volume of 7.5 M NH40Ac, 2 volumes of ethanol and frozen at -700C for 20
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min. Single-strand DNA (phage R408 DNA and single-stranded pS-N27)
was precipitated by centrifugation at 10 k rpm for 15 min at 4oc. The pellet
was rinsed with cold 70% ethanol, dried in a Savant Speed Vac and
resuspended in 20 µl of dH20. Two µl of the final product was checked by
electrophoresis in a 0. 7% mini-agarose gel prepared in 0.5 X TBE
containing 0.25 µg/ml ethidium bromide at 20 V overnight or at 50 V for 2-4
hours (see Fig. 5). Ml3mpl8 DNA (7.25 kb, from the USB sequencing kit)
and Lambda DNA Hind III fragments were loaded as the marker. The
molar concentration of the single-stranded DNA was roughly estimated by
measuring OD at 260 nm in a UV spectrophotometer.

Oligonucleotid.e synthesis and phosphorylation

Mutagenic oligonucleotides were synthesized by Dr. Basam Wakim
at Loyola University Medical Center. Degenerate oligonucleotides listed in
Table 1 were used for site-specific mutagenesis of the putative catalytic
residues Cys-1137 and His-1288, and two control residues Cys-1172 and His1317. Degenerate oligonucleotides listed in Table 2 were used for site
specific mutagenesis at the identified cleavage sites and its flanking
sequences (according to the nomenclature of Schechter and Berger, 1967)
including residues Arg-243 (P5), Gly-244 (P4), Tyr-245 (P3), Arg-246 (P2),
Gly-247 (Pl) Val-248 (Pl'), Lys-249 (P2') and Pro-250 (P3'), and also at the
previously suggested cleavage site Tyr-257 and Gly-258 (Soe et al., 1987).
These oligonucleotides contained degenerate sequences at positions which
would result in amino acid substitutions at specific residues of the MHVJHM

polymerase

polyprotein.

A

forward

primer

B67

(5'-
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Fig. 6. Agarose gel electrophoresis analysis of single-strand pS-N27 DNA.
Single-strand pS-N27 DNA (lanes 1and2) was prepared as described in the
Materials and Methods and analyzed by electrophoresis in a 0.7% agarose.
gel. Lambda DNA Hindlll fragments (lane M) and wild type bacteriophage
M13mp18 (lane M13, 7.25 kb) were used as the size markers. Singlestranded pS-N27 DNA (9.3 kb) and helper phage R408 DNA (6.4 kb) are
indicated.
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TableL

Wild-type

Amfnoacld
Cys-1137

OJigonucleotides used to generate sit.e specJfic mutations
in the MBVPCP-1 protelnaae domafn..

Mutagenic
oligonu.cleotide (IS' to 3')*

CGCAGCCAXXXA.TTAGTACGC

Mutation
Qxbi

Amino Acid

TAT
CGT
AGT
GGT
TGG

Arg
Ser
Gly

Tyr

Trp

His-1288

GCCATAG.AXXXGCAATCATT

ACA
CGT

Thr
Arg

His-1317

GTCATACC~CCCACCAT

CAG
GTG
TCT
CCG

Gln
Val
Ser

AAC
TCC

Asn
Ser

Cys-1172

CCACAAAGXXTTGATCATAGCC

Pro

w
00

4kQ

Table 2. Oligonucleotides used for site-directed mutagenesis of MHV-llIM p28 cleavage site and :flanking
amino acid sequence. (to be continued on the next page)

~tfon8f'1
Gly-247 (Pl)

Arg-246 (P2)

(s=tution
etter Code)
Ala (A)
Asp (D)
Val (V)

~~

Leu (L)
His (H)
Ser (S)
Tyr (Y)

Tyr-24S (P3)

Gly-244 (P4)

Arg (R)
Ser (S)
Phe (F)
Cys (C)

~ ~\

Val (V)
Asp (D)
Tyr (Y)
Phe (F)

Arg-243 (PS)

Ser (S)
Leu (L)
His (H)
Lys (K)

=on
t

Mutagenic oligonucleotide (S' to 3') •

GCT
GAT
GTT
AAT
CCC

AGGGOCTATCGCATTGTTAAG
GA

ere

CAC
TCC
TAC
CGT
TCT
TTT
TGT
CCI'
GCC
GTC
GAC
TAC
TTC
TCC

ere

Ile (I)
Thr (T)

CAC
AAA
ATA
ACA

Ala (A)

GCA

c

CTTAGGGGCTATCCCGGTGTTAAG
TT
A
CTTAGGGGCTATTCCGGTGTTAAGC
T
A
CTTAGGGGCCCTCGCGGTGTTT
TT

G
GCTCTTCTTAGGAC CTATCGCGGTGT
GT
A
GCTCTTCTTAGGTCCTATCGCGGTGT
CT
A
GCTCTTCTTAAAGGCTATCGCGGA
GT

c

w
\0

-~,,,~

Table 2. Oligonudeotides used for site-dhec:ted mutasenesis of MHV-JHM p28 cleavage site and flanking

amino acid sequence. (continued)

-~~
Val-248 (Pl'

=· =

\~u ~:~t.\
Ala (A)
Asp (D)
Oly (G)
Ser (S)

~~
Arg (R)
Lys-249 (P2'

Pro-250

(P3'

Tyr-257 (*)

Oly-258(•)

Leu (L)
Phe (F)
Ala (A)
Arg (R)
Met (M)
Thr (T)
Arg (R)
His

(H)

OCT
OAT
GOT
AOT
ACT

C.Ai

COT
CTT
TIT
GOO
AGO
ATO
ACO
CGC
CAC

Leu (L)

ere

Leu
Cys
Arg
Phe
Ala
Asp

CTT
TOT
COT
TIT
OCT
OAT

(L)

(C)
(R)
(F)
(A)
(D)

Mutagenic oligonucleotide (5' to

3' •

GGCTATCGCGGT AATAAOCCC

GC
G

GGCTAiCGCGGiCAiMOCJX
TG
T
TCGCGGTGTIGGGCCCATCCTG
AT

c

TCGCGGTGTIAAOTGCATCCTGTI
CA
T
GTGGACCAOCTTGOTIGCGAC
TG
G
GOACCAGTATGATTGCGACTATAC
TC

* Tyr-257 and Oly-258 dipeptide bond was previously predicted to be the p28 cleavage site (Soe et al, 1987).
• The complimentary sequences of mutagenic oligonucleotides are shown with degenerate sequences in bold.
.$)o.

0
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GGTAACAAAGGGTCTGTG-3', nucleotide 799 to 817 of MHV-JHM) was
synthesized for DNA sequencing at the putative cleavage site.

These

synthesized oligonucleotides (approx. 0.2 µmole, as dry powder) were
resuspended in 500 µl of dH20 and quantitated by measuring OD at 260 nm
in a UV spectrophotometer.

The mutagenic oligonucleotides are

phosphorylated at the 5' end by T4 polynucleotide kinase to increase the
ligation efficiency.

One hundred picomole of the diluted mutagenic

oligonucleotide was incubated with 5 u of T4 kinase in 50 mM Tris-HCl, pH
7.5, 10 mM MgCl2, 5 mM DTT, 0.1 mM spermidine and 1 mM ATP in a total
volume of 25 µl at 37oc for 30 min. The reaction was heated at 700C for 10
min to inactivate the kinase and stored at -2ooc until use.

Site-directed mutagenesis reaction
Site directed mutagenesis of pS-N27 was based on a coupled
annealing of the desired mutagenic oligonucleotide and another Ampr
oligonucleotide to the single-strand DNA templates (see Fig. 7) (Hutchison

et al., 1978; Lewis and Thompson, 1990). The single-strand pS-N27 DNA
served as the template for the site specific mutagenesis reaction. One and a
quarter picomole of one of the phosphorylated synthetic mutagenic
oligonucleotides (listed in Table 1 and Table 2) was annealed to 0.05
picomole of the single-stranded pS-N27 in conjunction with 0.25 picomole of
an Ampr oligonucleotide in 20 mM Tris-HCl, pH 7.5, 10 mM MgCl2 and 50
mM NaCl in a 20 µl reaction at 700C for 5 min and then cooled slowly. To
the annealing reaction, 1 µl of T7 DNA polymerase (10 u/µl, Promega), 1 µl
of T4 ligase (2 u/µl, Promega), 3 µl of the 10 X Synthesis Buffer (100 mM
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Fig. 7. Schematic diagram of Altered Sites in vitro mutagenesis procedure
(from the Promega protocol book). pS-N27 constructed as described in the
Materials and Methods is the recombinant plasmid here, in which the
insert (about 3.5 kb) is the MHV-JHM gene 1 cDNA from the plasmid pT7N27.

Single-stranded pS-N27 DNA was prepared as described in the

Materials and Methods and used as the template for a mutagenic reaction.
A mutagenic oligonucleotide, containing mutations at the MHV gene 1
region (see Table 1 and 2), was annealed to the single-stranded pS-N27 DNA
in conjunction with Ampr-oligonucleotide which can restore ampicillin
resistance to the mutated plasmid. The plasmid DNA was synthesized by
T4 DNA polymerase and ligated by T4 ligase.

The ligated DNA was

transformed into E.coli repair-deficient strain BMH 71-18 mut Sand then
JM109 which were subjected to ampicillin selection. The amplified mutant
plasmids were screened by direct DNA sequencing of the desired region.

43

Recombinant ssDNA
template (Amp•, Tet r)

1. Anneal ampicillin repair
oligo and mutagenic oligo.

~

Amp

oligo

Amp

Amp

8

I
t

r

l
l
l
l

2. SY.nthesize mutant strand
with T4 DNA polymerase
and ligate.

3. Transform BMH 71-18
mut S. Grow in media +
ampicillin.
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Tris-HCl, pH 7.5, 5 mM deoxynucleotide mixture with equal dATP, dGTP,
dCTP, and dTTP and 5 µl of dH20 was added and incubated at 37oC for 90
min for the minus-strand plasmid DNA synthesis. The ampicillin repair
oligonucleotide restores ampicillin resistance to the vector and the linking
of it to MHV-JHM gene 1 mutagenic oligonucleotides allows powerful
selection of mutants. A repair deficient E. coli strain (BHM71-18 mutS,
Promega) was transformed by the ligated DNA in a mutation reaction (30 µl
total). The bacteria were shaken in 0.5 ml of SOC medium (20 g/l Bactotryptone, 5 g/l Bacto-yeast extract, 0.5 g/l NaCl, 2.5 mM KCl, 10 mM MgCl2
and 20 mM glucose) for one hour at 37oc. Five ml of TYP broth containing
125 µg/ml ampicillin was added for an additional 8-14 hours of shaking to
amplify bacteria harboring mutant plasmids. Plasmid DNA was isolated
from BHM71-18mutS cells and an E.coli strain JM109 was transformed by
these mutated plasmid DNA. Individual ampicillin resistant colonies were
isolated to inoculate a 5 ml overnight culture with TYP broth containing 125
µg/ml ampicillin for minipreparations of plasmid DNA.

The prepared

plasmid DNA was sequenced across the region encompassing the
degenerate oligonucleotide binding site by double-stranded DNA sequencing
(USB Sequenase Version 2.0) to screen the desired mutants.

Plasmid DNA sequencing
Plasmid DNA sequencing was performed on the basis of Sanger's
dideoxynucleotide-mediated chain termination reaction using T7 DNA
polymerase (Sanger et al., 1977). Briefly, 2-3 µg of the double-stranded
plasmid DNA was denatured in 0.2 M NaOH, concentrated by ethanol
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precipitation and resuspended in 7 µl of dH20. One half pmol of the
sequencing primer was annealed to the single-strand pS-N27 DNA in a 20
µl reaction containing 40 mM Tris-HCl, 20 mM MgCl2, 50 mM NaCl, at 657ooc for 5 min and slowly cooled to sooc. The DNA synthesis was carried
out using 2 u of T7 DNA polymerase (freshly diluted to 1 u/µl, USB
Sequenase Version 2.0) for 2-5 min at room temperature after adding 1 µI of
0.1 M DTT, 2 µl of labeling mixture (freshly diluted to 1.5 µM of dGTP, 1.5
µM of dCTP, 1.5 µM of dTTP), 0.5 µl of 35S-dATP (10 µCi/µl, NEN). The
extended DNA product was labeled with 35S-dATP. Two and one half µl of
the chain extension reaction was randomly terminated by adding 3.5 µl of
each dideoxynucleotide (8 µM of ddGTP, or ddATP, or ddCTP, or ddTTP, in
80 µM of four dNTP and 50 mM NaCl) and incubated at 37oc for 5 min. The
sequencing reaction was stopped by adding 4 µl of Stop Buffer (95 %
formamide, 20 mM EDTA, 0.05% bromophenol blue, 0.05% xylene cyanol
FF). The reaction was analyzed by electrophoresis in a 5% polyacrylamide7M urea gel (Long Ranger, J. T. Baker).

The sequencing gel was

transferred to a Whatman 3MM paper, dried and exposed to a X-ray film at
room temperature. (see Fig. 8, a typical sequencing result for screening the
mutant plasmid)

Preparation of radiolabeled protein sample and N -terminal
microsequencing
To determine the p28 cleavage site, the radiolabeled C-terminal
cleaved protein product (100 kDa, or plOO) downstream of p28 processed
from the polyprotein encoded by pT7-N27 was selected for partial N-
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Fig. 8. Autoradiogram of representative sequencing result from screening
plasmid DNA encoding mutations surrounding the p28 cleavage site. The
sequencing result of two mutants: Ml (Lys) and M2 (Thr), and the wild
type: Wt (Arg) of Arg-243 at P5 position are shown. The codons for wild type

and mutants at position 243 are denoted at the left, and sequences of
nucleotide 932-952 of MHV-JHM gene 1 from the wild type are indicated at
the right.
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terminal protein sequence analysis which is based on Edman degradation
reaction (Matsudaira, 1987; LeGendre and Matsudaira, 1988). To obtain
significant amounts of in vitro translation products for protein sequencing,
large scale in vitro translation reactions were performed in a total volume
of 100 µl using 4.0 µg of pT7-N27 DNA linearized with EcoR I in the
presence of 80 µCi of 358-Met (Amersham), or 40 µCi 3H-Leu (ICN Biomed.),
or 40 µCi 3H-Val (ICN Biomed.) for 90 min at aooc. The in vitro translation
products were mixed with equal volumes of 2 X Laemmli Sample Buffer
and separated by electrophoresis in a 7.5% SDS-PAGE gel for 24 hours at 50
V.

Following electrophoresis, the translation products were electro-

transferred to Immobilon polyvinylidene difluoride (PVDF) membrane
(Millipore) at 40 V, 4oc, for 8-16 hours in buffer containing 25 mM tris-base,
192 mM glycine, 20% (v/v) methanol and 0.01 % (w/v) SDS. The PVDF
membrane was air-dried and exposed to a Kodak X-ray film at -700C. The
band of target protein labeled with 358-Met labeled proteins was identified by
autoradiography and the bands of corresponding proteins labeled with 3ff.
Leu or 3ff-Val (not visible) were co-localized in parallel to 358-Met labeled
proteins. These labeled proteins were excised from the membrane and
subjected to an Applied Biosystem gas-phase sequencer.

Partial N-

terminal amino acid sequence analysis was performed by Dr. Basam
Wakim at Loyola University Medical Center. Radioactivity released from
each cycle was quantitated by scintillation counting for 10 min in a
Beckman scintillation counter and then plotted to identify peaks of
radioactivity.

r
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CHAPTER III
RESULTS

Coronavirus polymerase is encoded by gene 1 located at the 5' end of
the viral genome. This gene (22 kb) is translated as a polyprotein with
multiple functional domains, including two papain-like cysteine proteinase
domains and one poliovirus 3C-like serine proteinase domain (see Fig. 2)
(Lee et al., 1991). These proteinases are proposed to proteolytically process
the polymerase polyprotein into mature and functional protein products.
An autoproteinase in the MHV-JHM polymerase polyprotein was shown to

be responsible for the cleavage of the amino-terminal peptide, p28 (Baker et

al., 1989). Computer-assisted amino acid sequence searches revealed that
this autoproteinase overlapped the putative first proteinase domain (PCP-1),
which has some sequence homology to the cellular cysteine proteinases
(Gorbalenya et al., 1991). The objective of the research reported in this
dissertation was to characterize the first papain-like cysteine proteinase
domain (PCP-1) and to identify the p28 cleavage site and its amino acid
sequence motif recognized by this proteinase.

Etrect of deletion mutation on prot.einase activity

The first proteinase domain was predicted to be at 3.5 to 4.2 kb from
the 5' end of the MHV-JHM gene 1 (Lee et al., 1991). To define more
49
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precisely this putative proteinase domain, a deletion analysis was
performed. Plasmid pT7-NBgl containing nucleotides 187 to 5273 of gene 1,
was used as the parental construct and generated three in-frame deletion
plasmids pT7-NAc, pT7-N27, and pT7-N29 (see Fig. 3). The plasmids were
transcribed by T7 RNA polymerase and translated in rabbit reticulocyte
lysates in the presence of 35S-Met, and the protein products were analyzed
directly or after immunoprecipitation with anti-p28 serum by SDS-PAGE
(Fig. 9A and B).

The pT7-NBgl translation yielded proteins of

approximately 188 kDa, 160 kDa, and 28 kDa (Fig 9A, lane 2). This result is
consistent with previous results which showed that the 188 kDa protein is
the primary translation product and the 160 kDa and 28 kDa proteins are
the products of an autoproteolytic cleavage (Baker et al., 1989). p28, the Nterminal cleavage product, is immunoprecipitated with anti-p28 antibody
(Figure 9B, lane 2). The p28 cleavage efficiency for pT7-NBgl translation
products was approximately 70%, as determined by quantitation of p28 and
the precursor polyprotein using a Betagen scanner. Truncation of a 0.9 kb
region at the 3' end of the PCP-1 domain in plasmid pT7-NAc had little
effect on proteinase activity.

It was demonstrated that p28 cleavage

efficiency of the polypeptide encoded by pT7-NAc was still approximately
70% (Fig. 9A and B, lane 3). Furthermore, deletion of an internal 0.74 kb
region between p28 and the proteinase domain had only a minor effect on
the ability of the proteinase to cleave p28 from the precursor polyprotein (6065% cleavage efficiency), as shown by translation of pT7-N27 RNA (Fig. 9A
and B, lane 4). These results are consistent with the prediction that the
proteinase domain is located in the region from 3.5 to 4.2 kb from the 5'-end
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Fig. 9.

Effect of deletion mutation on proteolytic processing of p28.

Linearized plasmid DNA was transcribed and translated in rabbit
reticulocyte lysates in the presence of T7 RNA polymerase and 358-Met as
described in Material and Methods. Equal TCA-precipitable radioactive
counts of translation products were analyzed by PAGE in 10%
polyacrylamide gels directly (A) and following immunoprecipitated with
p28-specific antiserum (B). Lanes: 1) no RNA, 2) pT7-NBgl RNA, 3) pT7NAc RNA, 4) pT7-N27 RNA, and 5) pT7-N29 RNA. Lane M contained 14Clabeled marker polypeptides; molecular weights are given in kilodaltons.
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and that some spacing sequences between the proteinase and p28 can be
deleted without abolishing p28 cleavage.

However, a larger internal

deletion of 1.6 kb (pT7-N29 RNA) resulted in an inability to cleave the p28
protein, and the appearance of two protein products of approximately 95
kDa and 90 kDa precipitable by p28 antiserum (Fig. 9B, lane 5). The 95 kDa
band was likely to be the primary translation product from the pT7-N29,
and the 90 kDa protein probably resulted from premature termination of
translation, or from a inefficiently proteolytic cleavage at an alternative
site. This result indicates that the internal region between the proteinase
domain and the p28 cleavage site may act as a spacing region to provide a
correct conformation essential for autoproteolytic activity. Alternatively,
the protein product encoded by this region may play a supporting role in the
processing of the polyprotein. Overall, these deletion studies supported the
prediction of a proteinase domain at the 5' end S.5 to 4.2 kb region of gene 1
and also suggested an important role for the spacing region between the
proteinase domain and the cleavage site (Baker et al., 1998).

Effect of proteinase inhibitors on the autoproteo]ytic activity of MHV PCP-1

There are four classes of proteinases which have been proposed from
the studies of cellular proteinases (Barrett and Salvesen, 1986). These four
proteinases are serine proteinases, cysteine proteinases, aspartic
proteinases and metallo-proteinases.

Representatives of each of these

proteinase classes have been found in viral systems, except for the
metalloproteinases (Krausslich and Wimmer, 1988; Dougherty and Semler,
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1993).

Computer-assisted sequence analysis suggests that the first

proteinase of murine coronavirus gene 1 is probably a papain-like cysteine
proteinase with the conserved Cys-1137 and His-1288 as the catalytic
residues (Gorbalenya et al., 1991). In order to determine ifMHV PCP-1 was
indeed a cysteine proteinase, we tested the sensitivity of the proteolytic
activity to a variety of proteinase inhibitors in rabbit reticulocyte lysate
translation reactions of in vitro transcribed pT7-N27 RNA (see Fig. 10 and
Table 3). The proteinase inhibitors tested included a general proteinase
inhibitor

ZnCl2, four cysteine proteinase inhibitors: cystatin,

Iodoacetamide, and N-ethyl-maleimide and E-64, a cysteine and serine
proteinase inhibitor leupeptin, a serine proteinase inhibitor APMSF [94(amidinophenyl)-methanesulfonylfluoride], an aspartic proteinase
inhibitor pepstatin A, and a metallo-proteinase inhibitor EGTA
{[ethylenebis(oxyethlenenitrilo)]-tetraacetic acid}. The effect of a wide range
of concentrations of each inhibitor on p28 processing was tested to achieve
the optimal concentration for each of these inhibitors.

The optimal

concentration had no effect on the overall efficiency of the translation
reaction but did inhibit specific proteinase activity. The optimal amounts of
these selective proteinase inhibitors were added to the in vitro translation
reaction of pT7-N27 RNA before the incubation at sooc. The 35S-Met labeled
translation products were analyzed by 10% SOS-PAGE gel and
autoradiography. The radioactivity of the precursor polyprotein and the
cleavage product p28 were quantitated by Betagen scanning to determine
the p28 cleavage efficiency (or the proteolytic activity of MHV PCP-1). The
cleavage efficiencies were normalized after setting the cleavage efficiency of
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Fig. 10. Inhibition of the proteolytic activity of MHV PCP-1 by proteinase
inhibitors. Approximately 200 ng of pT7-N27 RNA were translated in rabbit
reticulocyte lysates in the presence of 35S-Met as described in the Materials
and Methods. The optimal amount of the selective proteinase inhibitor was
added to the in vitro translation reaction of pT7 -N27 RNA prior to
incubation at 30°C for 90 min. The 35S-Met labeled protein product was
analyzed by electrophoresis in a 10% acrylamide -- 0.1 % SOS gel and
autoradiography. A. Lanes: 1) no inhibitors, 2) 0.1 mM ZnCl2, 3) 0.14 mM
cystatin.

B. Lanes:

1) no inhibitors, 2) 0.1 mM ZnC1 2, 3) 0.2 mM

iodoacetamide, 4) 2.5 mM N-ethyl-maleimide, 5) 0.5 mM E64, 6) 0.8 mM
leupeptin, 7) 1.00 mM APMSF, 8) 1.0 mg/ml pepstatin A and 9) 8.0 mM
EGTA.
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Table 3. Effect ofproteinase inhibitors on the autoproteolytic activity of the MHV PCP-1 proteinase.

Iphibitor

Proteinase Family

Concentration

Cleavage Efficiency

Inhibition(%)

No inln'bitor

------

------

100%

ZnCl2

general

O.lOmM

82%

18%

cystatin

cysteine

0.14mM

82%

18%

iodoacetamide

cysteine

0.20mM

82%

18%

N-ethyl-maleimide

cysteine

2.50mM

77%

23%

E-64

cysteine

0.50mM

82%

18%

leupeptin

serine/cysteine

0.80mM

91%

9%

APMSF

serine

1.00mM

100%

pepstatinA

~partic

1.0 ug/ml

100%

EGTA

metallo-

8.00mM

100%

Ut
00
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in vitro translation reaction without proteinase inhibitors as 100%. The
proteinase inhibitory effect was estimated roughly by comparing
radioactivity in p28 and precursor polyproteins and finally determined by
calculating the decrease of the cleavage efficiency in the presence of
proteinase inhibitors.

ZnCl2 was shown to inhibit proteolytic activity in previous studies
and used as the positive control (Denison and Perlman, 1986; Denison et al.,
1992; Baker et al., 1989). In the presence of ZnCI2 (Fig. 10 and B, lanes 2),
the intensity of p28 was decreased (as well as the intensity of the large
cleaved product plOO) as compared to the cleavage products of in vitro
translation without proteinase inhibitors (Fig. lOA and B, lanes 1).
Correspondingly, the intensity of the precursor polyprotein was increased
as compared to that from the negative control without the proteinase
inhibitor (Fig lOA and B, lanes 1 and 2), confirm that ZnCl2 inhibits the
proteolytic activity ofMHV PCP-1.

In the presence of four cysteine specific proteinase inhibitors:
cystatin, Iodoacetamide, N-ethyl-maleimide and E64, the relative ratios of
p28 to the precursor polyprotein were also decreased (Fig. lOA, lane 3; Fig.
lOB, lanes 3 to 5 ). And these specific cysteine proteinase inhibitors were
shown to inhibit proteolytic activity approximately to the same level as
ZnCl2. An inhibitor to both cysteine and serine proteinases, leupeptin, had
some inhibitory effect on the proteolytic activity (Fig. lOB, lane 6), consistent
with the published data (Denison et al., 1992).

In contrast, the
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representatives of the serine proteinase inhibitor--APMSF, the aspartic
proteinase inhibitor--pepstatin A, and the metallo-proteinase inhibitor-EGTA, showed little or no inhibition of the proteolytic activity (Fig. lOB,
lanes 7, 8, 9 respectively). The inhibition of the proteolytic activity of MHV
PCP-1 by inhibitors of cysteine proteinases but not by inhibitors of serine
proteinases, aspartic proteinases, and metalloproteinases supports the
hypothesis that MHV PCP-1 is probably a papain-like cysteine proteinase.

Effect of site-specific mutations of the putative MHV PCP-1 catalytic
residues Cys-1137 and His-1288 on proteolytic processing mp28

Amino acid sequence homology searches and the proteinase
inhibition studies described above suggested that MHV PCP-1 is a papainlike cysteine proteinase with characteristic catalytic residues of Cys and
His.

Among the Cys and His residues within the predicted proteinase

domain, Cys-1137 and His-1288 are the only two residues conserved among
all the cellular and viral papain-like cysteine proteinases and thus were
predicted to be the catalytic amino acids (Gorbalenya et al., 1991). To
determine if the predicted residues were indeed essential for catalytic
activity, these putative catalytic amino acids were altered by site-directed
mutagenesis (see Fig. 11). His-1317 and Cys-1172 in the proximity were also
altered by site-directed mutagenesis for comparison.

Site specific mutagenesis was performed by the method of
Hutchinson and co-workers (1978) using single-strand pS-N27 DNA and
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Fig. 11. The amino acid sequence of the proposed first papain-like cysteine

proteinase domain (PCP-1) of MHV-JHM gene 1. Cys-1137 and His-1288
marked by black triangles were predicted to be the catalytic residues of
MHV PCP-1 (Gorbalenya et al., 1989). The putative catalytic residues and
two control residues (marked by white triangles) were subjected to sitespecific mutagenesis analysis.

1101 F D A I Y S E T L S A F Y A V P S D E T H F K V C G F Y S P A I E R 1134
3416 'rl'OOATGCCATATACTCAGAGACG'l"l'GTCTGCA'rl'CTATGCl'G'roCCGAGT
TTCTA'l"l'CGCOGCTATAGMX:GT 3517

'v

1135 T N C W L R S T L I V N Q S L P L E F K D L G M Q .K
3518 ACTAAT'roTl'GGC'l'GCG'l'TACTrl'GATAGTAATGCAGAGTrl'ACC'rl"roGAATTT

L W L S Y K A G 1168
TGG'rl'G'l'CTTACAAGGC'roGC 3619

1169 Y D Q C F V D K L V K S A P K S I I L P Q G G Y V A D F A Y F F L S 1202
362 0 TA'l'GA'l'CAA'l'GC'rl"ro'l'AGTl'AAGAGCGCGCCCAAGTCTATl'ATl'C'l"l'CCACAAGG'roGCTA'ro'lOOCAGAT'.l'TroCCTA1"1"1"1"1"rt::CTAAGC 3721

1203 Q C S F K V H A N W R C L K C G N E L K L Q G L D A V F F Y G D V V 1236
3722 CAG'l'GTAGC'l"l'CAAAGTTCA'roCTAACTGGCGTTGTCTAAAGTGTGGCATGGAGTl'AAAGCTTCAAGGCTl'GGACGCCG'ro'rr1•rreTA'roGAGACGTl'G'ro 3823

1237 S H M C K C G N S M T L L S A D I P Y T F D F G V R D D K F C A F Y 1270
3824 TCTCATATGTGTAAGTGTGGTAATAGCA'roACCT'ro'l"ro'l'CTGCAGATATACCTl'ACACAT'l'CGA1"rl"IOOAG'l'GCGAGATGACAAA'l"l"l"Wl'GC'rl"l"l"tAC 3925

'

1271 T P R K V F R A A C A V D V N D C H S M A V V D G K Q I D G K V V T 1304
3926 ACGCCGAGAAAAG'l'C'l'TAOOGCTGCTl'GTGCGGT'l'GA'roTl'AATGATTGCCACTCTATGGC'l'G'l"l'GTGGA'roGCAAGCAAAT'l'GATGGTAAAGTTGTl'ACC 4027

v

1305 K F N G D K F D F M V G H G M T F S M S P F E I A
4028 AAATTTAA'l'GG'l'GACAAA'rrl'GATTl'TATGGTGGGTCATGGTATGACATTl'AGTA'roTCTCCCTl"l'GAGATCGCC

1329
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oligonucleotides containing degenerate sequences at the specific
nucleotides selected for mutation (see Table 2).

The procedures were

described in the Promega protocol of the Altered Sites in vitro mutagenesis
system (Fig. 7, in Materials and Methods), which uses a phagemid vector
pSELECT-1 (Lewis and Thompson, 1990).

The gene 1 fragment from

plasmid pT7-N27 (3.5 kb Pvu 11-EcoR I fragment) was inserted into the
polylinker region of pSELECT-1 (between the Sma I and BamH I sites), and
the recombinant plasmid was designated pS-N27. Single-strand pS-N27
DNA was prepared by standard methods and serves as the template for
mutagenesis reactions.

Plasmid DNA replication was primed by two

synthetic oligonucleotides:

one restores ampicillin resistance to the

plasmid and allows the selection of the mutant plasmids, and the other was
designed to encode mutations at specific codons of the

MHV gene 1

polyprotein. The two primers were added in excess so that they will be
simultaneously incorporated into the same DNA strand during replication
and produce double mutants selectable by ampicillin. Individual mutants
at each site were identified by DNA sequencing and listed in Table 1.
Plasmid DNAs encoding amino acid substitutions of each position were
linearized by digestion with EcoR I, transcribed and translated in vitro.
The 35S-Met labeled protein products with equivalent TCA-precipitable
radioactivity are immunoprecipitated by p28 specific antiserum and
analyzed by electrophoresis in a 10% polyacrylamide gel.

The putative catalytic residue, Cys-1137 was substituted to Tyr, Arg,
Ser, Gly, or Trp. The polypeptides containing these mutations all resulted
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in a total loss of p28 and corresponding increase of an uncleaved precursor
polypeptide (Fig. 12A). In contrast, mutations of Cys-1172 to Asn or Ser
revealed no alteration in the cleavage of p28 (Fig. 12B). The loss of the
proteinase activity by mutating Cys-1137 to a variety of amino acids of
different properties confirmed the importance of this specific residue.
Thus, Cys-1137 is indeed essential for the proteinase function.

Mutation of the putative catalytic residue His-1288 to Thr or Arg also
inactivated proteinase activity (Fig. 13A). Therefore, His-1288 as well as
Cys-1137 is an essential residue for the proteinase activity. Interestingly,
substitutions of His-1317 to Gin and Ser (Fig. 13B), also resulted in a 10-20%
reduction in the production of ·p28, as determined by quantitation of
cleavage products using a Betagen scanner. Substitution of His-1317 to Val
or Pro (Fig. 13B) resulted in significant reductions in proteolytic processing
to release p28.

In particular, the substitution of Pro at position 1317

completely eliminated the production of p28 and resulted in a primary
translation product which migrated slightly faster on the gel (Fig 13B).
This is not surprising since the addition of a Pro residue may cause
significant alteration in the protein folding. These data are consistent with
the idea that His-1317, considered as a non-catalytic residue of the
proteinase, may play a role in maintaining conformation of the proteinase
domain to allow accurate and efficient cleavage of p28.

The above site-mutagenesis analysis of Cys-1137, His-1288, Cys-1172
and His-1317 demonstrated that the catalytic residues of this proteiriase are
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Fig. 12. Effect of site-specific mutation at the putative MHV PCP-1 catalytic

residue Cys-1137 on proteolytic processing of p28. A series of mutants at
Cys-1137 and control Cys residue at position 1172 were generated by
oligonucleotide-directed single-strand DNA mutagenesis as described in
the Materials and Methods. Wild type or mutant plasmid DNA pS-N27 was
linearized by EcoR I digestion and used as the template in a coupled in vitro
transcription/translation reaction which was performed as described in the
Materials and Methods. Equal TCA counts of in vitro translation products
were immunoprecipitated by p28-specific antiserum and analyzed by 10%
SDS-PAGE. A. Lanes show products encoding the following amino acids at
the position 1137: no RNA, wild type (Cys), Tyr, Arg, Ser, Gly, and Trp; B.
Lanes show products encoding the following amino acids at position 1172:
no RNA, wild type (Cys), Asn, and Ser.

A
M

200- -

97-

N

Wt

,

Tyr Arg Ser Gly

68- -

Trp

M

N

Wt

Asn

Ser

200-

1J

97-

-·

68-

43-

29-

Cys-1172

--

-···
. :1 -.!J•

l· f ·1~
• I=--~

.

B

Cys-1137

43-

~p28

29-

. . p28

0\
0\

67

Fig. 13. Effect of site-specific mutation at the putative MHV PVP-1 catalytic
residue His-1288 on proteolytic processing of p28.

Various His-1288

mutants and control His-1317 mutants in pS-N27 were analyzed as in Fig.
12. A. Lanes show products encoding the following amino acids at position
1288: no RNA, wild type, Thr and Arg; B. Lanes show products encoding
the following amino acids at position 1317: no RNA, wild type, Gln, Val,
Ser, and Pro.
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Cys-1137 and His-1288, and that it belongs to the family of papain-like
cysteine proteinases (Baker at al., 1993).

Determining the amino-terminal amino acid sequence of the protein

.Uacent to p28
Studies on viral proteinases have shown that these proteinases have
a high degree of specificity for their specific cleavage sites (Dougherty and
Semler, 1993).

For example, in picornaviruses, proteinase 2A cleaves

predominantly at the Tyr(Pl)-Gly(Pl') dipeptide bond and proteinase SC
recognizes Gln/Glu(Pl)-Gly/Ser/Ala(Pl ') di peptide bond (Palmenberg,
1990). The specificity for cleavage is not only shown in the amino acids
forming the dipeptide bond to be cleaved or the scissile bond, but also in
some surrounding residues which may be important to maintain the
appropriate conformation for cleavage site presentation (K.rausslich and
Wimmer, 1988; Palmenberg, 1990; Dougherty and Semler, 1993). According
to molecular weight analysis, the p28 cleavage site is expected to be at
approximately 1 kb from 5' end of MHV gene 1. This region contains
several conventional cleavage sites (Tyr-Gly, Gly-Cys, Gly-Leu, etc.) similar
to the cleavage sites of poliovirus proteinases 2A, and Sindbis virus
proteinase nsP2. Previously, Soe et al. (1987) predicted Tyr-257--Gly-258 and
Tyr-272-Gly-273 as the potential candidates for the p28 cleavage site.

To identify the actual cleavage site, a direct approach was used to
isolate the cleavage product downstream of p28 and sequence its N
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terminus. The most critical point for conventional protein sequencing is to
prepare a sufficient quantity of protein sample {10-1,000 picomole, 0.5-50 µg
of a 50 kDa molecule). Since E. coli and yeast expression systems have been
developed, they are frequently used to overexpress eukaryotic proteins for
purification purposes. Previous studies have shown that viral proteinases
can be highly expressed in these systems and still retain their proteolytic
activities (Ivanoff et al. , 1986; Nicklin et al. , 1988; Alvey et al. , 1991). We
have tried an E.coli protein overexpression system (PET system, Novagen)
for expressing the gene 1 protein encoded in pT7-N27. However, it seems
that MHV PCP-1 is highly toxic to bacteria and we were unable to express
sufficient amounts of the protein product using this system.

To get around the limit of the requirement for microgram quantities
of the pure protein, we chose to isolate a radiolabeled in vitro cleaved protein
adjacent to p28 and subject the protein to amino-terminal microsequencing
(see Fig. 14). The protein was generated by in vitro transcription and
translation of our smallest in-frame deletion construct pT7-N27 which still
maintains active proteolytic processing of p28 (Baker et al., 1993). As shown
in previous deletion analysis of the PCP-1 domain, in vitro translation of
pT7-N27 generates a precursor polyprotein of 128 kDa which is
autoproteolytically cleaved by MHV PCP-1 to yield p28anda100 kDa protein
(plOO) (Baker et al., 1993). We found that pT7-N27 serves as an excellent
template for an efficient transcription and subsequent translation reaction
which can produces a large quantities of protein products. In addition, the
128 kDa precursor and 100 kDa C-terminal cleavage product were easily
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Fig. 14. Strategy of N-terminal protein sequencing to identify the p28

cleavage site. The radiolabeled C-terminal cleaved 100 kDa peptide (plOO)
downstream of p28 was generated by in vitro transcription/translation
reaction of pT7-N27 and targeted for N-terminal microsequencing to
determine the p28 cleavage site.
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resolved on a 7.5% SDS-polyacrylamide gel which allowed us to isolate the
target 100 kDa protein. Thus, in vitro translation products of pT7-N27,
labeled with either SH-Leu, SH-Val or S5S-Met were synthesized, separated
by electrophoresis in a polyacrylamide gel, and transferred to PVDF
membrane (Fig. 15). The 100 kDa protein was identified by autoradiography
and subjected to microsequencing as described in Materials and Methods.
The sequencing profile generated from samples labeled with SH-Leu
indicated that Leu occupied amino acid positions 5, 18 and 22 from the
cleavage site (Figure 16). Microsequencing of the 100 kilodalton protein
labeled with SH-Val revealed Val at positions 1 and 7 (Fig. 16).
Microsequencing of the 100 kDa protein labeled with S5S-Met indicated that
there was no Met at the first 25 positions from the cleavage site (data not
shown). By aligning this profile with the amino acid sequence deduced
from the MHV-JHM nucleotide sequence (Soe et al., 1987; Lee et al., 1991),
we identified the cleavage site for the generation of p28 as the Gly-247 (Pl)Val-248 (Pl') dipeptide bond (see Fig. 17).

Effect of sit.e-specific mutations surrounding the cleavage sit.e on proteolytic
processing of p28

To determine the amino acid sequence requirements for the PCP-1
recognition of the p28 cleavage site, we have targeted 8 amino acid residues
including P5 to P3' surrounding p28 cleavage site for site-directed
mutagenesis (see Fig. 18). A variety of site-specific mutants (total 42) at
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Fig. US. Schematic diagram of the autoradiogram of radiolabeled protein
electrotransferred to the PVDF membrane.

100 µl of pT7-N27 in vitro

translation products were separated in a 7.5% SDS-PAGE gel and
transferred to lmmobilon polyvinylidene difluoride (PVDF) membrane
(Millipore) as described in the Materials and Methods.

The

electrotransferred membrane was exposed to a X-ray film and
autoradiogramed.

The autoradiogram was matched with the PVDF

membrane to identify plOO labeled with 35S-Met in the membrane. 3ff-Leu
or 3ff-Val labeled plOO were not visible in the autoradiogram and were
localized in parallel to 35S-Met labeled plOO. All radiolabeled plOO was cut
out and subjected to automated N-terminal protein sequence analysis to
determine the p28 cleavage site.
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Fig. 18. N-terminal sequence analysis of radiolabeled plOO. plOO was
derived from the in vitro transcription/translation reaction of plasmid pT7N27 and were labeled with either 35S-Met, 3H-Leu, or 3H-Val.

The

radiolabeled samples on the PVDF membrane were identified by
autoradiography and subjected to microsequencing analysis based on the
Edman-degradation reaction.

Radioactivity released at each cycle was

quantitated using a Beckman scintillation counter and counts per minute
(cpm) were plotted. The amino acid sequence in single letter codes shown
at the top of the graph corresponds to amino acid 248 to 272 of the deduced
amino acid sequence of MHV-JHM gene 1.
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Fig. 17. Schematic diagram of the putative p28 cleavage site. Partial amino
acid sequence of the potential cleavage site region is shown, in which the
cleavage site Gly-247-Val-248 predicted from protein microsequencing
analysis is indicated by a black triangle and the previously proposed
cleavage site (Soe et al., 1987) is marked by an asterisk(•). The amino acids
underlined were targeted for site-specific mutagenesis analysis to further
characterize the sequence motif recognized by MHV PCP-1
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Fig. 18. Nomenclature of the amino acid residues surrounding a cleavage
site for a proteinase. The figure is modified from Dougherty and Semler,
1993, and the nomenclature was according to Schechter and Berger, 1967.
The peptide bond to be cleaved is indicated by an arrow, and amino acids
upstream of the scissile bond are designed as Pl, P2, P3, P4, P5, etc. and
amino acids downstream as Pl', P2', P3', P4', P5' , etc.

A schematic

proteinase domain is drawn at the bottom with the subsites (S5 through S5')
of the substrate binding pocket indicated. The complexity of the substratebinding pocket of an individual proteinase determines the requirement of
its cleavage site, or its specificity.
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Positions from P5 to P3' (see Fig.18) were created by single-strand DNA
mutagensis and isolated by direct plasmid DNA sequencing as previously
described (see Materials and Methods, Table 2). Individual mutant pS-N27
DNAs at each position were linearized by digestion with EcoR I, transcribed
and translated in vitro as described above. The 35S-Met labeled protein
products with equal TCA-precipitable radioactivity were directly analyzed
by 10% SDS-PAGE to determine the effect of amino acid substitutions on p28
cleavage (Fig. 19 to 26). Samples of in vitro translated proteins with
equivalent radioactivity were further analyzed by immunoprecipitation
with p28 specific antiserum, and the autoradiogram showed the amount of
p28 cleaved from the wild-type pS-N27 and mutant polypeptides at these
positions (Fig. 27).

As shown in Figure 19, mutation of Gly-24 7 at the Pl position to Ala,
Asp, Asn or Val resulted in a dramatic decrease in the yield of p28
generated by autoproteolytic processing of the mutant polyprotein.
However, mutation at the Pl position did not completely abolish proteinase
activity as is seen in a mutant of the catalytic site of PCP-1 in which the
catalytic residue Cys-1137 was mutated to Ser (Figure 19, lane C) (Baker et

al., 1993). When the products of the in vitro translation reaction were
immunoprecipitated with the anti-serum to p28, we detected two p28
specific bands (Figure 27, Pl position), indicating that a low level of
aberrant processing may also be taking place in the Pl mutants. Such
aberrant autoprocessing of a polypeptide encoding mutations in the
cleavage site has also been reported for the poliovirus 2A proteinase {Hellen
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Fig. 19. In vitro translation protein products of wild type pS-N27 and
mutants of Gly-247 (Pl).

Site-specific mutations were introduced by

degenerate oligonucleotide-directed mutagenesis as described in the
Materials and Methods. Linearized plasmids were translated in the T7
RNA polymerase coupled rabbit reticulocyte lysates in the presence of 35SMet and translation products were analyzed by 10% SOS-PAGE. Specific
mutations at the Pl position are indicated by amino acids A (Ala), D (Asp),
N (Asn), and V (Val) at the top of the corresponding lanes. Additional
lanes are: M, molecular weight marker; N, no RNA; Wt, wild type (Gly247) pS-N27 translation products; C, control polypeptide with inactive PCP-1
in which the catalytic residue of the proteinase, Cys-1137, was mutated to
Ser (Baker et al., 1993).
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et al., 1992). This aberrant processing may be due to an alteration in the
presentation of the cleavage site to the proteinase domain. Clearly, Gly-247
at the Pl position is an important determinant of the cleavage efficiency and
specificity of p28.

Like Gly-24 7 at the Pl position, mutation of Arg-246 at the P2 position
to His, Leu, Pro, Ser, or Tyr also resulted in dramatic reduction in cleavage
of p28 (Fig. 20 and 27). No p28 from all these mutant polyproteins was
detectable even after a long exposure of the SDS-PAGE gel. Thus, Arg-246
at the P2 position is also critical for efficient cleavage of p28. These results
indicate that the P2 residue (Arg-246) plays an important role for cleavagesite determination, which is consistent with the studies of the cleavage sites
for other viral cysteine proteinases in tobacco etch virus, and
Hypovirulence-associated virus (Carrington and Herndon, 1992; Shapira
and Nuss, 1991).

In contrast, mutations at the surrounding positions including P3,
P4, Pl', P2', and P3' had little or no effect on cleavage efficiency.
Polyproteins encoding mutations at the Pl', P2', P3', P3 or P4 positions
generally maintained equivalent cleavage of p28 as compared to the wild
type polyprotein (Fig. 21 to 25, and Fig. 27). At the P3 or P4 position, the wild
type has been selectively mutated from Tyr-245 to Cys, Phe, Pro, Arg, or Ser,
or from Gly-244 to Ala, Asp, Phe, His, Leu, Ser, Val, or Tyr, respectively.
Most of these substitutions result in drastic changes in the side chains of
the amino acids, but all the mutations had little or no effect on the cleavage
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Fig. 20. In vitro translation protein products of wild type pS-N27 and
mutants of Arg-246 (P2). Site-specific mutagenesis analysis was performed
as described in Fig. 19. Specific mutations at the P2 position are indicated
by amino acids Y(Tyr), S (Ser), P (Pro), L (Leu), and H (His) at the top of the
corresponding lanes and lane Wt represents wild type Arg-246 pS-N27
translation products.
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Fig. 21. In vitro translation protein products of wild type pS-N27 and
mutants of Tyr-245 (P3). Site-specific mutagenesis analysis was performed
as described in Fig. 19. Specific mutations at the P3 position are indicated
by amino acids C (Cys), F (Phe), P (Pro), R (Arg), and S (Ser) at the top of the

corresponding lanes and lane Wt represents wild type Tyr-245 pS-N27
translation products.
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Fig. 22. In vitro translation protein products of wild type pS-N27 and
mutants of Gly-244 (P4). Site-specific mutagenesis analysis was performed
as described in Fig. 19. Specific mutations at the P4 position are indicated
by amino acids A (Ala), D (Asp), F (Phe), H (His), L (Leu), S (Ser), V (Val),
and Y (Tyr) at the top of the corresponding lanes and lane Wt represents
wild type Gly-244 pS-N27 translation products.
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Fig. 23. In vitro translation protein products of wild type pS-N27 and
mutants of Val-248 (Pl'). Site-specific mutagenesis analysis was performed
as described in Fig. 19. Specific mutations at the Pl' position are indicated
by amino acids A (Ala), D (Asp), G (Gly), S (Ser), T (Thr), L (Leu), F (Phe), R
(Arg), and H (His) at the top of the corresponding lanes and lane Wt
represents wild type Val-248 pS-N27 translation products.
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Fig. 24. In vitro translation protein products of wild type pS-N27 and

mutants of Lys-249 (P2'). Site-specific mutagenesis analysis was performed
as described in Fig. 19. Specific mutations at the P2' position are indicated
by amino acids A (Ala), M (Met), R (Arg) and T (Thr) at the top of the
corresponding lanes and lane Wt represents wild type Lys-249 pS-N27
translation products.

95

Lys-249 (P2' )

Wt

A

M

U

'I'

96

Fig. 25. In vitro translation protein products of wild type pS-N27 and
mutants of Pro-250 (P3'). Site-specific mutagenesis analysis was performed
as described in Fig. 19. Specific mutations at the P3' position are indicated
by amino acids H (His), L (Leu), and R (Arg) at the top of the corresponding
lanes and lane Wt represents wild type Pro-250 pS-N27 translation
products.
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of p28 (Fig. 21 and 22).

At the Pl' position, which was shown to be

important for some viral cleavage sites, Val-248 (with small branched side
chain) was replaced by amino acids with similar small side chains (Ala,
Gly, Ser or Thr), amino acids with a large side chain or an aromatic chain
(Leu, or Phe), or charged amino acids (Asp, Arg, or His). All nine mutant
polypeptides had about the same or even slightly higher p28 cleavage as
compared to the wild-type polyprotein (Fig. 23 and 27). Thus, this result
enabled us to rule out the importance of the Pl' position for the cleavage site
determination. At two other positions (P2' and P3') downstream of the
peptide bond to be cleaved, substitutions of Lys-249 (P2') with Ala, Met, Arg,
or Thr, and Pro-250 (P3') with His, Leu, or Arg had no effect on p28 cleavage
(Fig. 24, 25 and 27). Thus, these five positions are less important for
cleavage site determination.

Interestingly, mutation of the P5 position, Arg-243, did have an
impact on the cleavage of p28. Mutation of Arg to Ala, Ile, or Thr resulted
in a significant reduction in p28 (Fig. 26 and 27). Substitution of Arg with
Lys, another similar positively charged amino acid, also reduced the
cleavage of p28 (Fig. 26 and 27).

This result is somewhat surprising

because Lys is the wild-type amino acid at this position in the A59 strain of
MHV. This observation raises a question as to the role of a different amino
acid at the P5 position for MHV JHM versus A59 (see Discussion). The
results of all the mutation analysis at the P5 position indicate that Arg-243
may play an important role, presumably a structural role, maintaining an
appropriate conformation of the cleavage site.
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Fig. 26. In vitro translation protein products of wild type pS-N27 and
mutants of Arg-243 (P5). Site-specific mutagenesis analysis was performed
as described in Fig. 19. Specific mutations at the P5 position are indicated
by amino acids A (Ala), I (Ile), K (Lys) and T (Thr) at the top of the
corresponding lanes and lane Wt represents wild type Arg-243 pS-N27
translation products.
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Fig. 27. Immunoprecipitation analysis of p28 from in vitro translation
products of wild type pS-N27 and mutants at positions from P5 to P3' of the
cleavage site. Site-specific mutagenesis on the positions from P5 to PS' was
performed as described in Materials and Methods. Translation products
were generated by in vitro transcription/translation of various pS-N27
plasmid DNAs and equal TCA-precipitable counts from each reaction were
immunoprecipitated using anti-sera specific to p28. Immunoprecipitation
products were analyzed by 10% SOS-PAGE. The region corresponding to
p28 is shown for each mutant. The amino acid at the site examined is
shown above each lane.
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Previous studies on proteolytic processing of p28 suggested that the
cleavage site for p28 generation is the Tyr-257 and Gly-258 dipeptide bond
(Soe et al.. , 1987). This suggestion was based primarily on a search of the
N-terminal region of the polymerase polyprotein for homology to a limited
number of known viral proteinase cleavage sites. Certain Tyr-Gly (Y-G)
sites (among others) are recognized by enterovirus 2A proteinases
(Palmenberg, 1990). Mutation of Tyr-257 to either Ala or Asp and of Gly-258
to Ala, Asp, Phe or Leu had no effect on p28 cleavage nor any effect on the
mobility of the p28 protein (Fig. 28). These results indicated that Tyr-257
and Gly-258 are not essential for proteolytic processing of p28. In addition,
the substitutions of residues at positions 257 and 258 do not appear to have
any effect on the presentation of the nearby authentic cleavage site Gly-247Val-248.

Overall, the results from our site-specific mutagenesis analysis at
eight amino acids surrounding p28 cleavage site Gly-247-Val-248, indicate
that Gly-247 at the Pl position and Arg-248 at the P2 position are the major
determinants for efficient cleavage of p28 by MHV PCP-1. In addition,
among the surrounding residues, Arg-243 at the P5 position may be
important, perhaps in maintaining a special conformation for the cleavage
site.

In summary, the studies of this dissertation showed that the first
papain-like cysteine proteinase (PCP-1) domain responsible for
autocleaving the N-terminal peptide p28 from the MHV-JHM polymerase
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Fig. 28. Effect of site-specific mutation at the previously predicted p28

cleavage site Tyr-257 and Gly-258 on proteolytic processing of pS-N27
translation products.

Site-specific mutagenesis was performed as

described in the Materials and Methods. Specific mutations at Gly-258 and
Tyr-257 are indicated by amino acids Ala, Asp, Phe, Leu, Lys, and Arg at
the top of the corresponding lanes. Additional lanes are: M, 14C-labeled
molecular weight polypeptide marker, masses are given in kilodaltons; N,
no RNA; Wt, wild type pS-N27 translation products.
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polyprotein is located at the 5' end 3.5-4.2 kb of gene 1. MHV PCP-1 is
indeed a member of the family of papain-like cysteine proteinases which
utilizes Cys-1137 and His-1288 as the catalytic residues. Additionally, MHV
PCP-1 cleaves at Gly-247 and Val-248 dipeptide bond to release p28. For this
p28 cleavage site, Gly-24 7 (Pl) and Arg-246 (P2) are major determinants,
and an important conformation is required for this cleavage site which
might be determined by some surrounding residues including Arg-243 at
the P5 position.

CHAPl'ER IV
DISCUSSION

Proteolytic processing of a polyprotein precursor is a common and
essential event in the replication of positive-strand RNA viruses including
retroviruses. Viral polyprotein precursors are processed into functional
subunits by viral and/or host cell proteinases (Krausslich and Wimmer,
1988; Dougherty and Semler, 1993). During replication of MHV, three viralencoded proteinase domains, PCP-1, PCP-2, and 3C-Pro, are proposed to be
responsible for separating the polymerase polyprotein (more than 750 kDa)
into functional protein products. To date, the activity of only the first
papain-like cysteine proteinase domain, PCP-1, has been demonstrated
(Baker et al., 1989). PCP-1 acts to autocleave the amino-terminal portion of
the MHV polymerase polyprotein, releasing p28 (Baker et al., 1989; 1993).
The goal of this dissertation was to understand this particular processing
event by characterizing the proteinase functional domain and the cleavage
site specificity of the proteinase.

This study demonstrated that the MHV-JHM PCP-1 proteinase
domain, which is responsible for the proteolysis of p28 protein from the Nterminus of the MHV gene 1 polyprotein, is located at 3.5-4.2 kb from the 5'
end of gene 1 (see Fig. 3 and Fig. 9). It was shown that some of the
intervening sequence between the proteinase domain and the cleavage site
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can be deleted without a significant effect on the proteolytic cleavage (Baker

et a/,., 1993). Also, the kinetics of p28 processing during in vitro translation
of the MHV genomic RNA (data not shown) suggest that p28 is cleaved as
soon as the proteinase domain is synthesized. Since the proteinase has
been shown to work in cis to release p28, p28 processing is probably a cotranslational event (Baker et al., 1989). In addition, it is likely that the
tertiary conformation of the polyprotein, particularly that formed by
sequences neighboring the cleavage site or the proteinase domain, are
critical for efficient proteolytic processing. This conclusion is supported by
the failure of pT7-N29, which has an internal deletion of 1.6 kb, to generate
p28.

To determine if MHV PCP-1 is a cysteine proteinase, we tested a
variety of proteinase inhibitors and monitored the effect of these inhibitors
on the proteolytic processing of p28. The level of p28 processing was shown
to be specifically reduced by cysteine proteinase inhibitors, but not by
inhibitors of serine proteinases, aspartic proteinases, and metalloproteinases (see Fig. 9). Furthermore, mutagenesis studies have identified
Cys-1137 and His-1288 as critical residues for the proteinase activity of
MHV-JHM PCP-1 (Baker et al., 1993). These two residues have been
proposed to be the catalytic residues of this proteinase on the basis of the
sequence similarity with cellular and viral papain-like cysteine proteinases
(Gorbalenya et al., 1991). The substitutions of amino acids of diverse
properties for Cys-1137 and His-1288 resulted in the total loss of proteinase
activity which confirmed that these amino acids are indeed at the catalytic
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center. In contrast, substitutions of the neighboring His-1317 or Cys-1172
residues did not inactivate proteinase activity, except for the Pro
substitution at the His-1317 position, which is expected to alter global
protein conformation. These studies thus strongly supported the computer
prediction that MHV PCP-1 is a new member of the family of papain-like
cysteine proteinases.

Coronavirus PCP-1 adds to the growing list of the viral papain-like
proteinases.

Previous studies have suggested that Sindbis virus (SV),

equine arteritis virus (EAV), rubella virus, hepatitis E virus, plant virus
tobacco etch virus (TEV) and hypovirulence-associated virus (HAV) all
contain proteinase domains with homology to the family of cysteine
proteinases and have conserved Cys and His residues essential for catalytic
activity (Gorbalenya et al., 1991; K.oonin et al., 1992; Dougherty and Semler,
1993). Among these viral cysteine proteinases, MHV PCP-1 appears to be
related to PCP in another coronavirus superfamily member, equine
arteritis virus (EAV) (den Boon et al., 1991; Snijder et al., 1992). EAV has a
similar replication strategy and genomic organization to that of
coronavirus MHV, but has only a 13-kb RNA genome. The product of the
EAV papain-like cysteine proteinase is a 30 kDa protein, which is also
derived from the N terminus of the ORFla protein of the polymerase gene,
but the cleavage site is located at the C-terminal end of the proteinase. Like
MHV PCP-1, this proteinase also acts only in cis (Snijder et al., 1992). For
both MHV and EAV, the function of the released amino terminal peptide
(p28 or p30) is not yet clear.
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The second question addressed in this research was the site
recognized by MHV PCPl for the cleavage release of p28. By N-terminal
protein sequence analysis of the in vitro cleaved protein downstream of p28,
the cleavage site for p28 was identified as the Gly-247 (Pl) and Val-248 (Pl')
dipeptide bond (Fig. 16 and 1 7). Site-specific mutagenesis of eight residues
surrounding the cleavage site from the P5 to PS' positions was performed to
further characterize the sequence motif of the p28 cleavage site. A total of
42 mutants were generated, with 3 to 9 mutants at each position. Mutations
at Pl Gly-24 7 and P2 Arg-246 dramatically decreased the amount of p28
cleaved from the mutant polyproteins compared to that from the wild type
polyprotein. In contrast, the majority of the mutations at the five other
positions (P3, P4, Pl', P2' and PS') had little or no effect on p28 processing
and only a few mutants led to significant p28 cleavage. Surprising results
were seen from the mutational analysis at the P5 position (Arg-243).
Mutation of Arg-243 to Lys, another positive charged amino acid also
reduced p28 cleavage as did three other mutations (Ala, Ile and Thr). The
P5 residue is the only residue that varies within positions from P5 to P3'
between two p28 cleavage sites of MHV..JHM and -A59 strains (Soe et al.,
1987; Pachuk et al., 1989). The observation that strain JHM prefers Arg at
the P5 position instead of Lys as in strain A59, is interesting, as it might
result from a minor difference between PCP-1 domains of A59 and JHM.

The extensive mutagenesis analysis of the cleavage site has shown
that Gly-24 7 at the Pl position and Arg-246 at the P2 position

are

major
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determinants of the p28 cleavage site recognized by MHV PCP-1. Since the
Arg-243-Gly-244 dipeptide, appears only three residues upstream of the
cleavage site (Arg-246--Gly-247), but is not recognized by MHV PCP-1, the
conformation of the p28 cleavage site Gly-247-Val-248 (unknown at this
point) or other surrounding amino acids must also be important for
defining the cleavage site. Surrounding residues such as Arg-243 (P5),
may be involved in maintaining the correct conformation of the cleavage
site or for interacting with the substrate-binding pocket of the MHV PCP-1
proteinase domain.

The Gly-Val dipeptide bond at the p28 cleavage site appears to be
similar to cleavage sites used by other viral papain-like cysteine proteinases
(see Fig. 29). The cleavage site for the amino terminal product of the equine
arteritis virus (EAV) polymerase polyprotein has been defined (Snijder et

al., 1992). The EAV papain-like cysteine proteinase (PCP) cleaves at a GlyGly dipeptide bond to release an amino terminal protein of 30 kDa. Snijder
and co-workers have demonstrated by site-directed mutagenesis that the
Gly residue at the Pl position was important for efficient autoproteolytic
processing whereas the Gly residue at the Pl' position was more flexible to
substitution (Snijder et al., 1992). In EAV, when the Pl Gly was replaced
with Ala, there was a reduction in the amount of p30 detected; when the Pl
Gly was replaced with Val, little or no processing of p30 was detected.
However, the Gly at the Pl' position was tolerant of mutation to Ala or Val
and proteolytic processing of p30 was detected.

112

Fig. 29. Comparison of known cleavage sites for viral papain-like cysteine

proteinases. Viral proteinases are indicated, and protein junctions cleaved
by Sindbis virus nsP2 proteinase are denoted. Amino acid sequences are
shown in single letter codes and the arrow indicates the dipeptide bond
being cleaved. MHV stands for mouse hepatitis virus, EAV for equine
arteritis virus, TEV for tobacco etch virus, HAV for hypovirulenceassociated virus, and SV for Sindbis virus.
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The best characterized cleavage sites for all identified viral cysteine
proteinases are in two plant viruses: the tobacco etch virus helper
component protease (TEV HC-Pro) and the proteinase p48 of hypovirulenceassociated virus (HAV) of the chestnut blight fungus. The cleavage site of
TEV HC-Pro is also at a Gly-Gly dipeptide bond and both residues (Pl and
Pl') are critical for efficient cleavage (Carrington et al., 1989; Carrington
and Herndon, 1992). There are two PCP proteinases (p29 and p48) reported
in HAV. HAV p29 and p48 utilize Gly-Gly and Gly-Ala as their cleavage
sites respectively.

The Pl Gly residue for both HAV cleavage sites is

required for efficient cleavage (Choi et al., 1991a; 199lb; Shapira and Nuss,
1991). Overall, a Gly at the Pl position is required by MHV, EAV, TEV and
HAV cysteine proteinases for efficient cleavage activity; but the Pl' residue
is somewhat flexible for MHV PCP-1, EAV PCP and HAV p48 recognition
and processing.

The amino acid residues surrounding these cleavage sites, the P2
and P4 residues of the cleavage sites for both HC-Pro and p48 have been
shown to be critical for the cleavage site determination. Similarly, the P2
residue of p28 cleavage site for MHV-JHM PCP-1 is a critical residue, but
the P4 residue does not seem to be as important for MHV PCP-1 cleavage as
it is for HC-Pro and HAV p48 cleavages. The difference in the sequence
motifs of these cleavage sites might result from the differences in the
substrate-binding pockets of these viral cysteine proteinases.
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Viral cysteine proteinases such as EAV PCP, TEV HC-Pro, and
HAV p29 described above have been termed "leader" viral papain-like
proteinases (Gorbalenya et al., 1991). These leader proteinases are located
near their N termini of the respective polyproteins and mediate a single
cleavage event in cis (or intramolecularly) at their own C termini. In these
polyproteins, the cleavage sites are located 50-100 amino acids downstream
of the catalytic cysteine residues (Snijder et al., 1992; Carrington et al., 1989;
Choi et al., 199la; 1991b). In contrast to the leader proteinase, the MHV p28
cleavage site (Gly-247-Val-248) is upstream of MHV PCP-1 and is separated
from the catalytic residue Cys-1137 of PCP-1 by almost 900 amino acids
(approximately 3 kb). We believe that MHV PCP-1 may be more similar to
Sindbis virus nsP2 (classified as a "main" proteinase by Gorbalenya et al.,
1991) which cleaves the polyprotein precursor at multiple sites both in cis
and in trans (Hardy and Strauss, 1989; de Groot et al., 1990, Shirako and
Strauss, 1990). Although MHV PCP-1 is so far only known to release p28
from the N-terminus of the polymerase polyprotein, it is possible that the
mature polymerase polyprotein may possess several sites which may be
cleaved in trans or in cis by MHV PCP-1. Questions remain about what the
mature form of the PCP-1 protein is and whether there are additional
cleavage sites in the polyprotein.

Compared to cellular proteinases, viral proteinases have been
shown to recognize specific amino acid sequence motifs (Dougherty and
Semler, 1993). The characterization of the cis-cleavage site of p28 for MHV
PCP-1 should help us predict additional cleavage sites in the polYJ>rotein.
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Indeed, there are 16 other Arg-Gly (RG) sites in MHV-JHM polymerase
polyprotein which may serve as potential targets for trans-cleavage by the
mature PCP-1 product. We plan to subject these RG sites (the major
determinants of the putative cleavage site recognized by MHV PCP-1) to
future investigation in order to determine which ones are in fact recognized
by the MHV PCP-1. These studies will help us to identify potential new
processed products of MHV polymerase polyprotein.

MHV PCP-1 is the first of three predicted proteinases in MHV
demonstrated to be active.

Interestingly, there is a second predicted

papain-like cysteine proteinase domain approximately 2 kb downstream
from the proteinase domain described here. MHV PCP-2 domain has a
higher sequence homology to the only PCP domain suggested in the chicken
coronavirus IBV ORFla polyprotein than does PCP-1.

The biological

activity of MHV PCP-2 domain has not yet been demonstrated. Because of
the finding that the first papain-like proteinase works only in cis and
requires at least some spacing regions between the cleavage site and the
proteinase domain, it seems unlikely that the downstream papain-like
proteinase domain will also cleave p28. Rather, it is more likely that the
second proteinase has other cleavage sites. Significantly, the IBV gene 1
polyprotein has only one PCP domain, a 3C-Pro domain (Gorbalenya et al.,
1989), and the N-terminal portion of ORFla polyprotein is substantially
diverged from that of MHV. IBV also lacks regions corresponding to p28
and the PCP-1 domain. Therefore, MHV PCP-2 may cleave in a region of
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the coronavirus ORFla polyprotein which is more conserved between

mv

and MHV.

The two papain-like cysteine proteinase domains are generally
believed to mainly process the polyprotein portion encoded from the MHV
ORFla, so the SC-Pro proteinase domain is probably responsible for the
processing of the polyprotein portion from the ORFlb which is about 300
kDa. Preliminary evidence suggests that MHV SC-Pro is active, and there
are multiple potential cleavage sites which have been predicted in the
ORFlb-encoded polyprotein by searching conventional poliovirus 3C
cleavage sites (Q/E-G/S/A) (Lee et al., 1991). Further confirmation of the
proteinase activity of MHV PCP-2 and SC-Pro domains are the prerequisite
for future studies of the complicated proteolytic processing of MHV
polymerase polyprotein.

The long term goal of the studies of the proteolytic processing of
MHV polymerase polyprotein is to define the complete proteolytic
processing pathway of this polyprotein.

Preliminary evidence has

suggested that a plethora of cleavage events are likely to occur during or
after translation of the coronavirus polymerase polyprotein (Denison et al.,
1991; 1992). Viral proteinases in Sindbis virus and poliovirus have been
shown to play a pivotal role in the regulation of processing and enzymatic
activity of viral nonstructural proteins including the polymerase protein
(Shirako and Strauss, 1990; Strauss and Strauss, 1990; de Groot et al., 1990,
Lemm and Rice, 1993; Shirako and Strauss, 1994; Dewalt and Semler, 1987).
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Conceivably, MHV proteinases may play similar roles in the regulation of
coronavirus replication. Future experiments can be directed to study the
functional importance of p28 processing in coronavirus replication by
introducing mutations at the p28 cleavage site by the unique high-frequency
RNA recombination observed in MHV. Ultimately, the functions of p28 and
other processed protein products of the polymerase polyprotein will be
pursued.

By studying the functions of all of these processed protein

products from coronavirus polymerase polyprotein, it is possible to
understand the molecular basis of the complex replication in coronavirus
replication.

Hopefully in the future, the studies of the molecular

mechanism of coronavirus proteolytic processing will provide useful
information for designing antiviral drugs to interrupt coronavirus
replication and block coronavirus infection and pathogenesis.
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